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A Study on Active Versus Expectant Management and Perinatal Outcome 
of Preterm Premature Rupture of Membranes Between 32-37 Weeks of 
Pregnancy 
ABSTRACT 
INTRODUCTION: 
PPROM is defined as a rupture of the amniotic membranes before 37 weeks of 
gestation and before the onset of labour. PPROM is one of the high risk factor 
leading to approximately one third of preterm births and it complicates about 
3% of pregnancies. It is associated with many neonatal and maternal 
complications including neonatal sepsis, hyaline membrane disease (HMD), 
placental abruption, and eventually fetal death. 
OBJECTIVES: 
1)To study active versus expectant management in preterm premature rupture of 
membranes (PPROM) between 32-37 weeks of pregnancy.2)To estimate the 
prevalence and identify the risk factors of preterm  premature rupture of 
membranes. 3) To study the perinatal outcome of preterm premature rupture of 
membranes. 
MATERIALS AND METHODS: 
This study was conducted in Govt. Kasturba Hospital, Triplicane, Madras 
Medical College, Chennai from December2012 to November 2013 with ethical 
committee approval. 108 patients with gestational age of 32-36 completed 
weeks (37 weeks) with confirmed ROM, Singleton pregnancy, primi and 
multigravida in the age group between 15-35 years were randomly allocated to 
active and expectant management groups. The admission, management 
procedures and events during delivery and puerperium and neonatal outcome 
were studied.  
RESULTS: 
The incidence of PPROM was 3.56%. It was high in 34-36 weeks of gestation. 
The mean MRO duration during admission was 14.91 hours, admission to 
delivery interval 15.81 hours. The incidence of  LSCS in active management is 
32.12 %  whereas in expectant group is 16.9%.The duration of mother 
hospitalization and post-operative complications like fever, abruption placenta 
were not statistically associated with active and expectant management 
(p>0.05). A statistically significant (p=0.007) differentiation in neonatal 
hospitalization, RDS were noted in both groups. Admission delivery interval 
was significant in both 32-34 as well as 34-36 weeks preterm PPROM. 
CONCLUSION: 
The incidence of PPROM is comparatively low because of improved living 
conditions and regular obstetric care. Active management by means of 
induction of labour between 34-36 completed weeks and expectant management 
between 32-34 weeks is safer for mother and fetus in pregnancies complicated 
by PPROM. 
KEY WORDS:   
Preterm premature rupture of membranes, RDS, Active management, Expectant 
management 
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INTRODUCTION 
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Introduction 
Pregnancy is considered a unique, physiologically normal episode in a 
women‟s life. While most pregnancies and births are uneventful, all 
pregnancies are at risk. Around 15% of all pregnant women develop a 
potentially life-threatening complication which in turn require a major 
obstetrical intervention to survive.
1 
Labour is a naturally occurring phenomenon which usually starts on its own. 
Labour is defined as the spontaneous onset of regular painful uterine 
contractions associated with the progressive effacement and dilatation of the 
cervix and descent of the presenting part, with or without a „show‟ or ruptured 
membrane.
2 
Preterm Labour (PTL) is defined by World Health Organization (WHO) as 
the onset of labour after the period of viability that is after 28 weeks of 
gestation and before 37 completed weeks or 259 days of pregnancy .It is 
estimated 15 million preterm births occur worldwide. Pre-term birth is 
associated with significant perinatal morbidity and mortality rates. About 35% 
of preterm birth follows preterm pre-labour rupture of membrane.  The early 
detection of preterm labour or preterm rupture of membranes in traditional 
antenatal care is problematic because symptoms or signs may vary only a 
little from the normal physiological symptoms and signs of pregnancy.
3
 
Hence detailed guidelines required to screen or manage pre-term labour. 
  2 
 
More than 1 in 10 of the world‟s babies born in 2010 were born prematurely, 
making an estimated 15 million preterm births (defined as before 37 weeks of 
gestation), of which more than 1 million died as a result of their prematurity. 
Preterm birth is divided into several categories, based on weeks of gestational 
age: 
1) Extremely preterm (<28 weeks) 
2) Very preterm (28 to <32 weeks)   
3) Moderate to late preterm (32 to <37 weeks).  
Moderate preterm birth may be further split to focus on late preterm 
birth (34 - <37 completed weeks). 
Preterm birth is a syndrome with a variety of causes which can be classified 
into two broad subtypes: 
 (1) Spontaneous preterm birth (spontaneous onset of  labour or following pre-
labour premature rupture of membranes (PPROM)) and 
 (2) Provider-initiated preterm birth (defined as induction of labour or elective 
caesarean birth before 37 completed weeks of gestation for maternal or fetal 
indications (both “urgent” and “discretionary”), or other non-medical reasons. 
Around 60% of preterm births in the world occur in Africa and South Asia, 
and it is truly a global problem. India had 3 519 100 preterm birth in 2010.
4 
Spontaneous rupture of membranes usually coincides with labour. Membrane 
rupture at term without spontaneous uterine contractions complicates 
approximately 8 percent of pregnancies. Induction implies stimulation of 
  3 
 
contractions before the spontaneous onset of labour, with or without ruptured 
membranes. So an orderly and systematic approach to labour management 
results in better maternal and perinatal outcomes.
5
 
Premature rupture of membranes (PROM) refers to the loss of integrity of 
membranes before onset of labour, with resulting leakage of amniotic fluid 
and establishment of communication between the amniotic cavity and the 
endo cervical canal and vagina. PROM occurs in approximately 5–10 % of all 
pregnancies, out of which around 80 % occur at term (term PROM).
6 
PPROM is defined as a rupture of the amniotic membranes before 37 weeks 
of gestation and before the onset of labour. PPROM is one of the high risk 
factor leading to approximately one third of preterm births and it complicates 
about 3% of pregnancies. It is associated with many neonatal and maternal 
complications including neonatal sepsis, hyaline membrane disease (HMD), 
placental abruption, and eventually fetal death. The risk of fetal death in 
PPROM is 1 to 2%. In addition, PPROM puts the mother at risk for infection 
(chorioamnionitis) and premature delivery, and increases the risk of lower 
segment Caesarean section delivery.
7 
 
Preterm pre-labour rupture of the membranes (PPROM) is an important 
clinical problem and the management option creates a dilemma for the 
obstetrician. On the one hand, waiting for spontaneous onset labour 
  4 
 
(Expectant line of management) may lead to an increase in infectious disease 
for both mother and child, whereas on the other hand induction of labour 
(Active line of management) leads to preterm birth with an increase in 
neonatal morbidity and a possible rise in the number of instrumental 
deliveries.
8
  
 
The aim of this study is to systematically compare the induction of labour and 
expectant management in case of preterm premature rupture of membranes 
between 32 and 37 weeks in terms of neonatal sepsis and RDS, maternal 
health, health-related quality-of-life and costs. 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
REVIEW OF 
LITERATURE 
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Review of Literature 
Definition 
ROM: Spontaneous rupture of membranes (ROM) is a normal component of 
labour and delivery. 
 
PROM: Premature rupture of membranes (PROM) refers to rupture of the 
fetal membranes prior to the onset of labour from 37 to 42 weeks of gestation. 
Since it ruptures before the onset of labour it is also referred to as pre-labour 
rupture of membranes. PROM can occur either at term or preterm 
(<37weeks). Prolonged PROM refers to PROM greater than 24 hours, and is 
associated with an increased risk of ascending infection. 
 
PPROM: Preterm PROM defined as premature rupture of membranes 
occurring prior to 37 weeks of gestation.
9
 
Latent period- Time from rupture of the membranes up to delivery. 
Latent -
interval 
Time from rupture of the membranes to the beginning of the  
active phase of labour.
10 
Incidence 
The incidence of PPROM is 
0.5% before 26weeks 
 6 
 
1.0% between 26 and 34 weeks 
1.5% between 34 and 37 weeks. 
It accounts for about one fourth of all cases of ruptured membranes. PPROM 
is responsible for close to 40% of preterm births.
11 
 
Structure of Fetal Membranes 
In humans the foetal membranes are composed of the amnion and the chorion. 
The amnion is the innermost of the two human fetal membranes and, as such, 
it is in contact with the contents of the amniotic sac which includes the 
amniotic fluid, the foetus and the umbilical cord. The chorionic membrane, 
which is attached to the outer surface of the amniotic membrane, separates the 
amnion from the decidua and the uterus .
12 
 
Structure of Amnion 
The Amnion is derived from ectoderm and it is composed of two layers –
inner and outer layer. The inner layer lies near to amniotic cavity and outer 
layer lies near to myometrium of uterus. The amnion is composed of five 
layers of cells and measures around thickness of 0.02 to o.5 cm.  It is 
avascular and nerveless. The cells are cuboidal to columnar in shape and 
undergo squamous cell metaplasia at areas of mechanical stress. The amnion 
has got a single layer of epithelial cells which is strengthened by the cells‟ 
surface chromosomes and microvilli inter-digitations. The amnion overlies a 
 7 
 
basement membrane composed of type IV and V collagens that attach to a 
collagenous extracellular matrix consisting predominantly of type I and type 
III collagen, reticular fibrils and fibroblasts. 
 
Structure of Chorion 
The Chorion is derived from mesoderm that originates from the 
trophoblastic mass. The trophoblastic villi undergo atrophy as the embryo and 
gestational sac grow away from the implantation site towards the opposite 
wall of the intrauterine cavity. The cells are arranged in 2-10 layers and are 
polygonal in shape. The thickness of Chorion is 0.4 mm.  In contrast to the 
amnion the Chorion is vascular, and it carries the nutrients in its vessels. The 
amnion receives its nutrients from chorion by the process of diffusion. 
 
Etiopathogenesis 
PPROM is a multifactorial in nature. The fetal membranes are composed of 
the amnion and chorion which are bound together by different layers of 
extracellular matrix. This matrix is the key factor for maintaining the 
elasticity and tensile strength of fetal membranes. The tensile strength of the 
membranes which in turn acts as a physical and functional boundary for the 
growing fetus during pregnancy. 
13  
If the extra cellular matrix is intact, 
 8 
 
elasticity and tensile strength of the fetal membranes is at its maximum; hence 
any process that interferes or weakens the elasticity and tensile strength of the 
matrix metallo proteinases (MMPs) increases the risk of PPROM. 
 
Risk Factors 
-Infection of the woman‟s genital  tract (nonspecific vaginosis, 
Trichomonasvaginalis, Mycoplasma hominis, Chlamydia trachomatis, 
Neisseria gonnorhoe, streptococci of group B (GBS), other sexually 
transmittable diseases(STD) 
-PPROM in previous pregnancies (21%)
 14 
- Premature uterine activity 
- Multiple pregnancies 
- Antepartum haemorrhage 
- Incompetence of cervix 
- Polyhydramnios 
- Placenta praevia and other placental disorders 
- Congenital anamolies of uterus 
- Condition after interventions on the cervix (conization, cerclage) 
- Coitus 
- Low socio-economic status related to poor nutrition 
- Cigarette smoking 
-   Maternal diseases like α1 AT deﬁciency and Ehlers - Danlos syndrome   
 9 
 
- Maternal vitamin and mineral deficiencies.
15
    
 
Premature rupture of membranes is multifactorial in nature. In any patient 
with PPROM, one or more pathophysiologic processes may be evident. The 
most common risk factor for PPROM is infection. 
16
 The commonest germs 
associated in complicated cases of PPROM are: Chlamydia, Mycoplasma, 
group B Streptococcus.
10
 
 
Choriodecidual infection or inflammation appears to play an important role in 
etiology of PPROM, particularly at early gestational ages. In PPROM women 
the membrane collagen content has been decreased with increasing 
gestational age. In support of this, there is an increase in amniotic fluid matrix 
metalloproteases (1, 8, and 9) as well as a decrease in tissue inhibitors of 
matrix metalloproteases (1 and 2) have been identified among women with 
preterm PROM.
16
 
Collagen is produced by fibroblasts and degraded by a family of enzymes 
known as matrix metalloproteinases (MMPs). During the process of labour, 
the membrane strength weakens in response to an up-regulation of matrix 
metalloproteinase-9. The action of MMPs is normally controlled by tissue-
specific inhibitors of their activity (TIMPs). In PPROM, there will be 
 10 
 
disruption of the balance between MMP and TIMP activity, which is the final 
event that results in collagen degradation and eventual membrane rupture. 
Menon et al showed   that following infection there will be  increase in local 
inflammatory mediators such as tumour necrosis factor-alpha (TNF- α) and 
interleukins-1, 6, and 8 and which in turn up-regulate MMPs and inhibit 
TIMPS leading to degradation  of collagen and eventual membrane rupture.
17
 
An another study by Mercer et al shows the association of  decreased 
membrane collagen content in preterm  PROM and with increasing 
gestational age. The same study shows the presence of increased amniotic 
fluid matrix metalloproteases (1, 8, and 9) decreased tissue inhibitors of 
matrix metalloproteases (1 and 2) in women with preterm PROM.
18
  
The risk factors of PPROM acts through different pathways that up-regulate 
the inflammatory process. Infection is the major risk factor that leads to 
recruitment of activated neutrophils and macrophages. These activated cells 
have the capacity to kill bacteria by releasing reactive oxygen species (ROS) 
that destroy the bacterial cell wall. The ROS released and hypochlorous acid 
is also capable of damaging the fetal membrane directly and acts as a signal 
for the up-regulation of MMPs.  
Smoking and cocaine abuse generate ROS which induces tissue damage and 
inflammation via lipid peroxidation.
16
 Subchorionic hemorrhage that is 
 11 
 
manifested as vaginal bleeding stimulates inflammation and membrane 
damage by at least three different pathways. First, the iron released from the 
lysed erythrocytes will act as a catalyst to generate the hydroxyl radical, a 
potent and short- lived ROS. Second, thrombin in the clot directly enhances 
decidual cell production of MMP-3.
19
 Finally, platelets in the clot stimulate 
the release of chemoattractants, via the CD-40 ligand system, that recruit 
inflammatory cells to the site of bleeding. 
20
   
Micronutrients and infection and inflammation during pregnancy:  
Preterm PROM has been attributed to the effects of matrix-degrading 
enzymes on the fetalmembranes, and reduction-oxidation status may affect 
the activity of matrixmetalloproteinase 9, an enzyme responsible for 
membrane rupture. Studies showed the dose response relationship between 
the plasma ascorbic acid concentration and prevalence of premature rupture of 
membranes, in patients with poor nutritional status.
21
 
 
Vascular lesions of the placental bed have been described in patients with 
PPROM, including failure of normal physiologic transformation of the 
decidual segment of the spiral arteries, thrombosis, and atherosis. Studies 
have shown an increased incidence of maternal vascular lesions in patients 
with preterm premature rupture of membranes than normal pregnancies 
(35.1% PPROM patients vs. 11.8% in normal pregnancies).
22 
 12 
 
There are studies showing, relaxin as one of the component in the mechanism 
of membrane rupture. Laboratory experimentation has shown the relaxin 
induced collagenase activity when incubated with membranes in vitro.
23
 
 
Bogic et al study shows the overexpression of relaxin gene in the membranes 
PPROM women when compared with those from women in preterm labour 
with intact membranes or from women not in labour. 
24
 Some studies have 
indicated that the relaxin mediated pathway of PPROM is independent of 
infection.
25
 
 
Age 
The incidence of PPROM is more in younger age group. It is 43.2% in 26–30 
years age and 23.3% in > 30 years group. 
26
 It was seen to be common among 
patients who were young (15–25 years) 58.8%.27 
 
Diagnosis of PPROM 
The diagnosis of PPROM requires a thorough history, physical examination, 
and selected laboratory studies. Patients often report a sudden gush of fluid 
with continuous leakage .The history of patient alone has the sensitivity of 
90% for diagnosing PPROM.
28 
 
 13 
 
Speculum Examination 
Rupture of membranes was assessed clinically with a sterile speculum 
examination and visualising the passage of amniotic fluid through the cervical 
os and pooling of the amniotic fluid in the posterior fornix of the vagina. If 
there is no pooling of fluid in vagina the patient is asked to perform valsava 
maneuver such as coughing or fundal pressure is given to evaluate the leakage 
of fluid from the cervical os. Whenever preterm PROM is suspected, it is 
always important to avoid performing a digital cervical examination because 
such examinations have associated with increase morbidity. 
28
 
 
 If rupture of membranes cannot be determined by a Speculum examination, 
other tests like the nitrazine paper test and the fern test may be performed to 
diagnose PPROM. The combination of the patients history, speculum 
examination, the nitrazine test, and the fern test for evaluating a patient with 
symptoms suggestive of PPROM yields a sensitivity of 93.1 %(Gold et al).
29
 
 
Nitrazine Test 
The pH of vagina during pregnancy 4.5 to 5.5 and pH of amniotic fluid is 7 to 
7.5. pH of vaginal secretions would rise to 6.0 when  it is contaminated by 
escaping amniotic fluid causing the nitrazine paper to turn from yellow to 
blue in colour. The colour of the paper remains yellow or changes to olive 
 14 
 
yellow (pH 5.0-5.5) when the membranes are intact. The nitrazine test may 
give false positive results if contaminated with semen, blood, some lubricants, 
or if a vaginal infection is present. The nitrazine test has got 16.2% false 
positive and 12.7% false negative results. Like nitrazine paper, litmus paper is 
also used to detect changes in vaginal pH. When vagina is bathed with 
amniotic fluid red litmus paper turns into blue colour. 
 
Fern Test 
Ferning occurs due to drying of salts that present in amniotic fluid. This test is 
done by collecting fluid from posterior fornix or sidewalls of vagina and 
allowed to dry on a glass slide for 10 minutes the microscopic appearance of 
ferning or arborisation pattern indicates positive test. In 1944 this ferning or 
arborisation was used for the first time to diagnose PPROM with sensitivity 
of 96-99% and specificity of 98-99% 
10
. A false positive result may obtain 
due to presence of cervical mucous and vaginal blood.
28
 The fern test gives 
4.4% false positive and 4.8% false negative results .
30 
Fetal Fibronectin  
Fetal fibro nectin is an extra cellular glycoprotein secreted by chorionic tissue 
at maternal and fetal interface and it is present in large quantities in amniotic 
fluid. It can be detected in ectocervix of vagina by ELISA with an FDC-6 
monoclonal antibody. A cut off value of 50ng/ml is considered positive. The 
 15 
 
sensitivity and the specificity of fetal fibronectin in diagnosing PROM were 
94.5 and 89.1 % .
31
 In multiparas, a positive cervico vaginal fetal fibronectin 
test was also associated with PPROM. Nulliparas with a positive fetal 
fibronectin and a short cervix had a 16.7% risk of preterm birth because of 
PPROM, whereas multiparas with a previous history of PPROM, a short 
cervix, and a positive fetal fibronectin had a risk of 25 % in PPROM.
32
  
Dye Test 
It is an USG guided invasive test, mainly used for PPROM. The main 
indication of this test is in women with clinical history consistent with 
PPROM and negative nitrazine and fern test. This test consists of 
intraamniotic injection of 1 ml of indigo carmine diluted with 9 ml of distilled 
water. A tampon is placed in vagina and examined visually after 30 minutes. 
The presence of blue discolouration in tampon is diagnostic of PPROM. 
Methylene blue dye is not used now a days because of the risk associated with 
hyperbilirubinemia and haemolytic anaemia in infants.
28, 33 
Amnisure 
PAMG -1(Placental microglobulin -1) is a protein secreted by cells of 
decidual part of placenta. This protein is present in amniotic fluid after 
rupture of membranes. AMNISURE is a new generation test that detects 
 16 
 
PAMG-1 by immunochromatographic method. This is a highly diagnostic test 
with 99 % of sensitivity and 100% of specificity .
34 
Ultrasound 
Ultrasound examination showing oligohydramnios is also used to help 
confirm the diagnosis of PROM. It also helps in detecting the position of the 
fetus, presenting part, placental location, estimated fetal weight, and presence 
of any anomalies.
28
 It is also useful in assessing fetal biometry for estimation 
of gestational age, cervical length, funnelling or dilatation of cervix. 
Other tests in PPROM includes 
1) Detection of alpha fetoprotein in amniotic fluid 
2) Detection of fetal cells in amniotic fluid (Nile blue sulphate test) 
3) Microscopic detection of lanuga hair and vernix caseosa in amniotic 
fluid 
Complications of PPROM 
I-Neonatal Complications 
II-Maternal Complications 
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Neonatal Complications 
Prematurity 
It is the most common complication of PPROM. In 80% of women with 
PPROM delivery occurs within 7 days leading to high perinatal morbidity and 
mortality.
35
 
Hyaline Membrane Disease 
It is the most important threat when the baby is delivered before 37 weeks of 
gestation. The incidence of RDS is estimated to decrease from 15% at 34 
weeks to below 1% at 37 weeks' gestation.
36, 37
 The incidence of RDS was 
22.5% in 33 weeks and 5.8% in 34 weeks.  It was relatively low after 34 
weeks; it still affects neonates up to 36 weeks with incidence of 10.4% in 35 
weeks and 1.5% in 36 weeks. The incidence of respiratory distress was nearly 
4.5- fold higher in the preterm patients than in the term patients.
38
 
 
Infection 
Fetal infection is the major complication in mid trimester PPROM. Studies on 
very low birth weight infants has shown that neonates born with infection are 
associated with increased incidence of sepsis.
39
 The incidence of sepsis 
increases when expectant management is advocated. In case the child is born 
immediately after PPROM, the risk of sepsis is 2.5%, whereas it increases to 
 18 
 
7.5% in case of expectant management.
36
 E.coli is the commonest organism 
responsible for neonatal sepsis .The incidence of sepsis is 36.4% at 24 weeks, 
24.4% at 27-28weeks, 1.6% at31-32 weeks and 0.8% 33-34weeks. 
 
Neurological Damage 
In 6-12% of PPROM infants hypoxia, inflammation and prematurity 
contributes to neurological damage (Yoon et al 1999).
40 
 
Pulmonary Hypoplasia 
This occurs when PROM occurs before 26 weeks and the latent period is 
prolonged for more than 5 weeks. In PPROM the pressure gradient between 
the amniotic cavity and alveoli is altered. As a result there is a loss of fetal 
lung fluid into the amniotic cavity, leading to pulmonary hypoplasia. The 
incidence of pulmonary hypoplasia is 50% at 19 weeks, 10% at 25 weeks and 
rare after 26 weeks.
41
 
 
Cerebral Palsy 
It is a long term sequelae of PPROM especially in patients complicated with 
chorioamnionitis, intra ventricular haemorrhage, intrapartum fetal acidosis 
and hypoxia.
42  
 
 
 19 
 
Musculoskeletal Deformities 
Facial and skeletal deformities can occur due to prolonged PROM. 
Deformities in prolonged PROM are due to severe oligohydramnios. Like 
pulmonary hypoplasia, most of these cases occur in PPROM before 26 weeks 
and after a latency period of 5 weeks or more.
43
 
Maternal Complications 
 Acute chorioamnionitis 
The incidence of Chorioamnionitis in all pregnancies is 0.5% to 1% and 
PPROM patients are 0.5% to 71%. The incidence of chorioamnionitis in 
PPROM increases with decreasing gestational age and with the duration of 
membrane rupture.
38 
Diagnosis of chorioamnionitis is based on the clinical presentation  
-Maternal fever > 38° C with any 2 of the following:  
- Maternal tachycardia (> 100 bpm)  
-Fetal tachycardia (>160 bpm)  
- Uterine tenderness  
- Offensive vaginal discharge 
 - Increased white cell count (> 15 x 109 / L)  
- C Reactive Protein >2.7 mg/dl 
 20 
 
- Histological examination of placenta and membranes with evidence of acute 
inflammation may confirm the diagnosis after birth.
44
 
The  incidence of chorioamnionitis is 58.6% in  patients with PROM before 
28 weeks whereas  the incidence  PROM occurring  after 36 weeks is less 
than 10%
45
 .The reason for high incidence of acute chorioamnionitis and 
neonatal infection  in PPROM are due to decreased antibacterial activity of 
amniotic fluid
46,47
 . In early pregnancy, the amniotic fluid antibacterial activity 
is low and it increases with gestational age. Also the immature immunological 
system of the fetus limits the preterm infants from fighting against infection. 
Acute chorioamnionitis may present at the time of admission or it may 
develop during the latency period in women do not have signs of infection at 
the time of admission. In these cases, the incidence of infection is related to 
the duration of latency period. Butchers (1964) found that 1.7% of his patients 
with PROM developed fever within 24 hours, 7.5% between 25-48hours and 
8.6% beyond 48 hours. The incidence of histologic chorioamnionitis at 12 
hours after rupture of the membranes is 10%, after 24 hours is 30%, after 48 
hours is 45%, and after 72 hours is 48%.
14
 Ghidini et al., have found that there 
is no increase in histologic chorioamnionitis with the increase in the duration 
of latency period.
48
 Another factor that predisposes to chorioamniotic 
infection is internal fetal monitoring. Newton et al determined by logistic 
regression analysis that the chance of developing chorioamnionitis in  patients 
who had 20 hours of PROM  and 3 hours of internal fetal monitoring was 
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20%. This probability was increased to 40% if the latency period was more 
than 20 hours and internal fetal monitoring lasted for 12 or more hours. 
 
Subclinical chorioamnionitis 
 
The  bacteriologic studies on  amniotic fluid   by  Romero et al  has shown  
that 40% of patients with PPROM during admission  are infected ,but only a 
few patients will develop signs and symptoms of overt infection . Most of the 
times, uterine contractions are the only symptom of chorioamniotic infection. 
Other signs of subclinical infections are an absence of respiratory movement 
in biophysical profile and a change from a reactive to nonreactive pattern in 
Non Stress Test.  It can be detected by the elevated C-reactive protein in 
blood samples of PPROM patients. Studies have shown that estimation of C-
reactive protein was superior to cervical swab culture, placental culture, urine 
culture, and histology in detecting subclinical infection in cases of PROM.
49
  
 
Placental Separation 
 
The incidence of abruptio placentae is approximately 6% in patients with 
PPROM which is significantly higher than the 1 in 150 found in patient with 
intact membranes.
50
 Abruption usually occurs in PPROM when there is 
prolonged and severe oligohydramnios. It usually presents as preterm labour 
with mild to moderate vaginal bleeding. Fetal demise or disseminated 
intravascular coagulation due to abruption occurs rarely. The cause for 
abruption in PPROM patients is due to progressive decrease in intrauterine 
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surface area, leading to placental detachment. Placental abruption occurs in 
upto 50% of PPROM prior to 20 weeks gestation (Fortunato et al)
 .42 
 
Postpartum Endometritis 
Postpartum endometritis mainly occurs in mid trimester PPROM. It is more 
common in patients who develop chorioamnionitis and are delivered by 
caesarean section. The incidence has been reported to be between 15-60%, 
whereas the reported incidence of postpartum maternal sepsis lies between 0 - 
3%.
51
 
Role of Corticosteroids 
Corticosteroids should be given in cases with preterm PROM between 24 and 
32 weeks‟ gestation to reduce the risk of intraventricular  hemorrhage, 
respiratory distress syndrome, and necrotizing enterocolitis .
28
 The National 
Institutes of Health recommends administration of corticosteroids before 30 to 
32 weeks‟ gestation, assuming fetal viability and with no evidence of intra-
amniotic infection. Use of corticosteroids between 32 and 34 weeks still 
remains controversial. Corticosteroids administration after 34 weeks of 
gestation is not recommended. It can be administered after 34 weeks if there 
is evidence of fetal lung immaturity by amniocentesis. 
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 Current ACOG recommendations 2007  
A single course of antenatal corticosteroids is recommended for women with 
PROM before 32 weeks' gestation to reduce the risks of  
1) Respiratory distress syndrome 
2) Perinatal mortality 
3) Other morbidities.
52
  
A single course of corticosteroids is recommended for pregnant women 24-34 
weeks' gestations that are at risk of preterm delivery within 7 days. If 
pulmonary immaturity is documented, corticosteroid treatment at 32-33 
weeks of completed gestation may be beneficial. Corticosteroid is not 
recommended before 28 weeks of gestation as there is no sufficient data. A 
single rescue course of antenatal corticosteroids may be considered if the 
antecedent treatment was given more than 2 weeks prior, the gestational age 
is less than 32 6/7 weeks, and the woman is judged by the clinician to be 
likely to give birth within the next week. However, repeated administrations 
of more than two courses are not recommended. 
 
Role of Antibiotics  
The role of prophylactic antibiotics for patients with PPROM is to reduce the 
risk of neonatal infections and to prolong the latency period. A few 
randomized control studies have shown that there is a prolongation of the 
latency period by 5-7 days, and a reduction in the incidence of postpartum 
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endometritis and neonatal sepsis.
54,55
 Prolonging the latency period is 
important because FLM improves with increasing gestational age, resulting in 
reduction in the hospital stay for the new born. It has been found that each day 
of intrauterine life in preterm fetus will reduce 2-3 days of neonate stay in 
NICU after birth. The National Institute of Child Health and Human 
Development trial 25 shows an use of intravenous combination of  ampicillin 
2 grams and  erythromycin 250 mg every six hours for first 48 hours, 
followed by  amoxicillin  250 mg and erythromycin 333 mg every eight hours 
for the next five days. Co-amoxiclav is not recommended for women with 
PPROM because of concerns about necrotizing enterocolitis. 
NIH Maternal Fetal Collaborative Group and the Oracle I Randomised Trial 
show that the incidence of severe IVH, pneumonia, neonatal sepsis, and 
necrotizing enterocolitis are reduced with the use of ampicillin or 
erythromycin. There is no effect of antibiotics in respiratory distress 
syndrome.  There is no evidence to recommend regarding the duration of 
antibiotic therapy. It is important that antibiotics given should be effective 
against GBS and E.coli. Azithromycin can be given if chlamydia is present in 
culture and Rocephin is added if N.gonorrhoea is present. The most common 
regimen used is cefazolin 2 g IV every 8 hrs for 48 hrs followed by oral 
cephalexin 250 mg for 5 days. Recent studies suggested that the results are 
similar with or without oral therapy.
56, 57 
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Tocolytics in PPROM 
PPROM is one of the major causes of preterm deliveries and perinatal 
morbidity; hence the use of tocolysis may be appealing to the obstetrician 
.However the use of tocolysis in PPROM cases remains controversial.  There 
have been several randomized controlled studies regarding the use of oral 
tocolytics in PPROM, intravenous tocolytics, and short term and long term 
tocolysis 
58
.But all these studies have failed to show decreased perinatal 
morbidity or improvement in neonatal outcome. However, tocolysis can be 
useful in women with contractions during admission who may deliver before 
the glucocorticoid administration. Aggressive tocolysis after PPROM does 
not prolong the pregnancy or reduce neonatal mortality more than a limited 
treatment for a few days.
59
 There is no clear first line tocolytic drug. The 
choice of drug should be individualised and is based on the maternal 
condition, potential side effects of drug and gestational age of the patient. 
(ACOG 2003) 
 
Management 
The initial evaluation of PPROM should include a detailed history taking, a 
sterile speculum examination to confirm the diagnosis of rupture of 
membranes. Cervical cultures for Chlamydia trachomatis and Neisseria 
gonorrhoeae and vaginal cultures for Streptococcus agalactiae should be 
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obtained. The other laboratory investigations like complete blood count 
including the total number of white blood cells and differential count   and 
estimation of C - reactive protein should be done.  Maternal vital signs should 
be monitored and continuous fetal monitoring is also done to find out the fetal 
status. Ultrasonography should be done to establish the gestational age, fetal 
presentation, fetal weight and amniotic fluid index. The duration of latency 
period, the mode of management of patient and the maternal and fetal 
prognosis are dependent on gestational age at the time onset of PROM. 
Therefore, an accurate assessment of gestational age is an important tool in 
initial evaluation of PPROM patients. An ultrasound examination done during 
the first trimester of pregnancy is extremely accurate in the  estimation of 
gestational age.
60
 Likewise, a  gestational age derived from  the second 
trimester  ultrasound  does not differ by more than 1 week from the 
gestational age based on last menstrual period. If the ultrasound derived and 
the LMP derived estimations of gestational age differ by more than1 week, 
the gestational age derived by ultrasound will be more accurate and it should 
be taken for clinical management.
61
 It is important to consider that the 
decrease in amniotic fluid in case of PPROM affects the accuracy of 
ultrasound measurements and it leads to underestimation of the gestational 
age.
62
 
Speculum examination is used to assess the cervical dilatation instead of 
digital examination. It has been shown that digital cervical examinations in 
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PPROM decreases the latency period and increases the chances of infections 
without providing any additional useful clinical information.
53
 It has been 
found that digital  examination of cervix will cause an average decrease of 
nine days in the latent period.
28
 
In certain conditions of PPROM, immediate delivery of the fetus is indicated. 
These conditions include 
1) Chorioamnionitis 
2)  Advanced labour 
3) Fetal distress 
4) Placental abruption  
5) Non reassuring fetal surveillance. 
 If there is documented fetal lung maturity either by collecting vaginal fluid or 
amniocentesis, delivery should be initiated. In a non-cephalic presentation of 
fetus with advanced cervical dilatation (3 cm or more), the risk of cord 
prolapse is more and the risk may outweigh the benefits of conservative 
management and immediate delivery should be considered. 
After the initial evaluation of the mother and fetus, if both are found to be 
clinically stable, expectant management of PPROM can be considered to 
improve fetal outcome. The most common maternal risk associated with 
expectant management of PPROM is infection. This includes 
chorioamnionitis (13-60%), endometritis (2-13%), sepsis (< 1%), and 
maternal death (1-2 cases per 1000). Placental complications like abruption 
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(4-12%) and retained placenta or postpartum hemorrhage requiring uterine 
curettage (12%) can also occur.
53
 
The management of PPROM depends on the gestational age at the time of its 
occurrence. This is due to the difference in the incidence of fetal/ neonatal and 
maternal complications at different gestational age. 
 
PPROM at 36 Weeks 
Women with PROM occurring after 36 completed weeks should be delivered. 
After 36 weeks there is only a little gain by conservative management when 
the pregnancy has advanced to the stage at which the pulmonary maturity of 
fetus is complete or almost complete and there is minimal incidence of 
Respiratory Distress syndrome.
63 
 
PPROM between 32 to 36 Weeks 
Approximately 50% of the fetuses of women with PPROM between 32 and 
36 weeks of gestation will have adequate lung maturity. Spinnato et al found 
that there is no difference in neonatal outcome between expected management 
and immediate delivery in 47 patients with premature rupture of membranes 
before 36 weeks with documented foetal lung maturity. However, they 
demonstrated an increased risk of maternal infection when expectant 
management was applied. 
36.64
 Mercer et al (1993) did a randomised trial in 
between 32 to 36 weeks and found that there is an increased chance of 
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chorioamnionitis, prolonged maternal and neonatal hospitalization and 
prolonged antimicrobial therapy in the neonates of women with expectant 
group. 
65
 
 
The management of women in PPROM between 32 and 36 weeks is matter of 
discussion among experts. There are several studies favouring immediate 
induction.
65, 66
 Expectant management with steroids and antibiotics decreases 
the incidence of RDS, which is the most common neonatal morbidity in this 
group. 
16,
 
67
 
Hence the care of these patients should be individualized. Immediate delivery 
by induction may be the best options in certain conditions like 
chorioamnionitis, oligohydromnios, non-reassuring fetal cardiac activity, 
patients in active labour and transverse lie. In women with conservative 
management should be hospitalised until delivery. Intravenous antibiotics 
should be given for 48-72 hours followed by oral treatment for 5-7days. Daily 
electronic fetal monitoring should be done. Patients should be assessed for 
fever, maternal or fetal tachycardia, foul smelling discharge and uterine 
tenderness. The role of glucocorticoids in preventing RDS in PPROM woman 
between 32-36 weeks is controversial. Similarly incidence of IVH is rare after 
32 weeks. 
The main benefit of the conservative management is prolonging pregnancy 
and to decrease the gestational age-related morbidity associated with 
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prematurity, but the benefit must be balanced with the risks of conservative 
management, like clinical chorioamnionitis. Many studies have demonstrated 
the advantages in conservative management for gestations of less than 34 
weeks, whereas the management of pregnancies complicated by PPROM 
between 34 and 37 weeks continues to be a contentious issue .
66 
Proponents 
for delivery at 34 weeks, argue that because of the lack of significant neonatal 
benefit in prolonging   the pregnancy until 37 weeks, early delivery is justified 
to reduce the risk of chorioamnionitis. .  
A Cochrane review for Women with PPROM prior to 37 Weeks of gestation 
was published in 2010 (Buchanan, 2010), concludes that there is not sufficient 
evidence to guide clinical practice regarding the benefits and harms of 
immediate delivery compared with expectant management.
19 
 
 
PPROM between 24 and 32 weeks 
 
Delivery before 32 weeks in PPROM patients is associated with severe 
neonatal morbidity and mortality. The predominant risk factor is RDS usually 
due to HMD, affecting 30-100%. Other common morbidities associated are 
sepsis, affecting from 10- 50%; Intra Ventricular Haemorrhage affecting 
about 5-50%, 
 Chronic lung disease affecting around 2-80% and necrotizing enterocolitis 
affecting 1-10 %. All of these complications are related directly to gestational 
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age at the time of birth and will be more frequent and severe it occurs in 
pregnancies less than 28 weeks. 
 
The aim of the management of women with PPROM between 24 and 32 
weeks is prolonging the latency period, preventing the incidence of RDS and 
IVH, and preventing the fetal/neonatal and maternal infectious morbidity and 
mortality. These things can be achieved by the use of antibiotics, steroids and 
tocolytic agents. Contraindications to conservative therapy include 
chorioamnionitis, non-reassuring fetal testing and abruptio placentae.   
Women with PPROM between 24 and 32 weeks should be hospitalised and 
remain as in patients until delivery.  These patients in conservative 
management should be on bed rest with adequate facilities. 
  
PPROM before 24 Weeks 
The survival  rate of newborn that is born before 24 weeks is very low (Iess 
than 20-25%).The perinatal mortality  in PPROM before 24 weeks is very 
high (60-90 %).  About 48%, 67%, and 83% of these patients in this group 
will deliver within 3 days, 1 week, and 2 weeks respectively. (Moretti and 
sibai et al). Approximately 50% of mothers will develop choriooamnionitis, 
50% of mothers will be delivered by caesarean section, and abruption occurs 
in 6.8% of patients. 16% of the surviving new born will have a severe long 
term sequelae. Most of the survivors are patients who extend their latent 
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period for 2 weeks or more. Some of the patients have prolonged latency 
period for several weeks after PPROM without any evidence of infection with 
little or no liquor amnii. They are associated with high risk for fetal 
musculoskeletal deformities and pulmonary hypoplasia. Deformities usually 
appear when the PPROM prolongs to 4 or more weeks. 
 
If the pregnancy is less than 24 weeks the fetal morbidities should be dicussed 
with the mother and family and the mother should be given the choice of 
induction of labour and conservative management.  If the patient chooses 
termination of pregnancy it should be made clear that there is only 10-20% 
probability that the fetus will be born alive. If the mother does not want to go 
for termination and chooses expectant management, she will be treated with 
antibiotics, tocolytics and glucocorticoids. If the patient is less than 24 weeks 
and if the maternal and fetal conditions are satisfactory she may be sent home 
and readmitted in hospital after 24 weeks for further expectant management. 
 
Surgical Approaches to the Treatment of PPROM 
 
The exact site of rupture of membranes can be visualized endoscopically.
68
 In 
spontaneous rupture the site is usually located above the internal cervical os 
whereas in traumatic rupture, following amniocentesis, or fetal surgery, the 
site is far from the cervix. Immediately after rupture, the slit in the 
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membranes has clean, sharp edges which become irregular with the passage 
of time.  Various experimental approaches have been used to seal the rupture 
site. Earlier there were attempts made by using fibrin glue which is prepared 
from mixing thrombin with cryoprecipitate. Amniopatch was created by 
successive intra-amniotic injections of platelets and cryoprecipitate for 
traumatic rupture.
69
This method is not useful in patients with spontaneous 
rupture. It may cause sudden fetal death in some cases due to the release of 
toxic substances by the activated platelets. Trans cervical application of 
commercial fibrin tissue sealant made up of thrombin and cryoprecipitate has 
been tried.
70
 Gelatin sponge embolization is also used in the surgical 
treatment for PROM.
71
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Aim of the study 
 To study active versus expectant management in preterm premature 
rupture of membranes (PPROM) between 32-37 weeks of pregnancy. 
 To estimate the prevalence and identify the risk factors of preterm  
premature rupture of membranes 
 To study the perinatal outcome of preterm premature rupture of 
membranes.  
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Materials and Methods 
This study was conducted in Institute of Social Obstetrics, Govt. Kasturba 
Gandhi Hospital for Women and Children under Madras Medical College, 
Chennai for the period of one year from December 2012 to November2013. 
Institutional Ethics Committee approval was obtained from Madras Medical 
College for this study. 
Study Method 
This was a prospective study which was carried out among pregnant women 
came with preterm premature rupture of membrane from 32 weeks to 36 
weeks 6 days(37 weeks) of gestational age. Sample size was calculated to 108 
by using 7.72%
72
 prevalence of PPROM with 5% precision. 
Sampling Frame 
The study participants of 32 weeks to 36 weeks 6 days were divided in to two 
groups 
1. 32-34 weeks completed gestational age group 
2. 34-36 weeks completed  gestational age group 
For presentation purpose 32-34, 34-36 and 32-36 were used instead of 
additional six days in 34 and 36 gestational age. All the study participants 
enrolled in both the groups were further randomised to active and expectant 
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management group.  The pregnancy outcomes of above two groups were 
studied. The study groups were given in below diagram. 
 
 
 
 
 
Inclusion criteria 
Pregnant Women with Gestational age between 32-36 weeks 6 days with 
 Singleton pregnancy 
 Primi and multigravida 
 Previous LSCS 
 Age group between 15-35  years 
 Confirmed cases of leaking 
Exclusion criteria  
 Multiple pregnancies 
 Features of chorioamnionitis 
 Meconium stained liquor 
 Severe oligohydromnios 
Study Participants-32-36 weeks (108) 
32-34 weeks A 34-36 weeks B 
Expectant 
Management 
Group II 
Active 
Management 
Group I 
Expectant 
Management 
Group II 
Active 
Management 
Group I 
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 Active labour 
 Non reassuring  fetal heart rate in CTG 
 Major congenital anomalies 
 Medical or obstetric complications indicating prompt delivery 
The study participants with history of PPROM were admitted and PPROM 
was confirmed by sterile speculum examination, nitrazine test/fern test. 
The gestational age was ascertained by LMP and first trimester dating 
ultrasound. If there is disparity of more than 7 days between the two then 
gestational age was assumed as per USG. And maternal temperature, pulse, 
blood pressure and fetal heart rate were recorded.  
Investigations 
 All the baseline investigations like Hb, blood sugar, blood grouping and 
typing, HIV, VDRL and urine albumin and sugar were done. High vaginal 
swab was taken at the time of admission for culture and sensitivity. A sterile 
speculum examination was done to assess the bishop‟s score initially. Then 
further digital examinations were strictly prohibited  
Expectant Management 
The patients who were managed expectantly were observed in labour room. 
The fetal conditions were monitered by continuous external fetal heart 
monitoring and non-stress test. In the absence of initiation or progression of 
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labour, non-reassuring fetal conditions and absence of infection these patients 
were transferred to antepartum room where periodic assessment of maternal 
and fetal conditions was done. Modified biophysical profile was done daily 
till delivery. Delivery was either by spontaneous onset of labour or 
termination of pregnancy due to development of chorioamnionitis, non-
reassuring fetal status in non-stress test and development of severe 
oligohydramnios. Termination is done by oxytocin induction and caesarean 
section was done for obstetric indication.  
Active Management 
 In this group, labour was induced either by intra cervical instillation of PgE2 
gel or continuous infusion of oxytocin depending on the bishops score. A 
continuous intravenous infusion of oxytocin starting with a dose of 5mIU/min 
and doubling of dose is done till delivery of the patient. 0.5 mg of PgE2 gel is 
kept intra-cervically and bishop‟s score was assessed after 6 hours and then 
labour was accelerated by continuous oxytocin infusion. 
In both the groups progress of labour was monitored carefully by partogram 
and Caesarean section was done only for obstetric indications. 
All the patients in both the groups irrespective of duration of rupture of 
membranes, will be given intravenous Ampicillin 2 gm
 
8 hourly for first 48 
hours followed by oral amoxicillin 500 mg every 8 hours for 7 days or till the 
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patient goes into labour and delivers  to reduce the infections. And single 
course of corticosteroid where given in 32-34 weeks group. 
In puerperium, all patients will be followed clinically and investigated for 
evidence of infection (endometritis). Clinical parameters considered for 
maternal morbidity were fever, tachycardia, abdominal tenderness, foul 
smelling lochia, sub involution of uterus, and evaluation of stitch line. And 
other maternal outcome was recorded. 
All the neonates were examined by paediatrician. Neonatal morbidity was 
considered in cases of neonatal septicaemia, convulsions, or with birth 
asphyxia and death. The neonatal sepsis was confirmed by blood culture and 
sensitivity. Respiratory Distress Syndrome (RDS) was defined for our study 
as early onset of tachypnea, retractions, and oxygen requirement for 24hrs or 
mechanical ventilation with radiographic confirmation. 
All the information was collected in pre-tested questionnaire. All the study 
participants were assessed until they get discharged. The study was conducted 
after getting consent from the study participants. 
Statistical analysis 
All the data were entered in Microsoft Excel. Statistical analysis was done 
using SPSS version 12. Proportion, nonparametric test and independent 
sample „t‟ test. Study outcome is composite variable of Delivery interval, 
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vaginal delivery, LSCS, Maternal morbidity, Neonatal morbidity, mean 
hospital stay between two groups.  
Benefit to the participants 
Close monitoring of all preterm premature rupture of membranes patient‟s 
management and identify best method of management of preterm premature 
rupture of membranes. 
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Observation and Analysis 
The study of management of Pre-term Premature rupture of membrane 
management was conducted in Madras Medical College- Govt. Kasturba 
Gandhi Institute of Social Obstetrics, Triplicane, Chennai from the period of 
December 2012 to November 2013 of one year duration. 
There was 7656 admission of pregnant women for delivery purpose during 
the study period. Out of the total admission in this category in the hospital 
381 were presented with pre-term premature rupture of membrane. And 273 
cases were excluded and 108 cases were included in our study. The selection 
process of study participants was given in Figure1. 
Figure 1. Study participants in the study 
 
 
 
 
 
 
 
 
Total Admissions for delivery 
7656 
 
Total PPROM cases 
381 
Excluded PPROM cases 
273 
 
------- 
Total selected PPROM cases for study 
108 
Total Put in Expectant Management 
53 
 
Total put up in Active management 
55 
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The incidence of PPROM in the study was 3.56% during study period. 
Socio demographic indicators of study participants: 
Figure 2. Number of study participants 
 
The majority of the study participants were in the age group of 20-25 years 
(57%). And 26% were in the age group of 25-30 years, 5% in 30-35%, 12% in 
15-20%. 
Table 1.Age distribution and educational status of study participants (n=108) 
Age group 
(yrs) 
<6
th
 
Std 
 
% 
6
th
 to 
10
th
 
Std 
 
% 10
th
 to 
12
th 
Std 
 
% Degree 
 
% Total 
15-20 3 23.1 5 38.5 3 23.1 2 23.1 13 
20-25 22 35.5 25 40.3 11 17.7 4 6.5 62 
25-30 10 35.7 12 42.9 5 17.9 1 3.6 28 
30-35 3 60.0 1 20.0 1 20.0 0 0.0 5 
Total 38 35.2 43 39.8 20 18.5 7 6.5 108 
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Most of the study participants (39.8%) were studied 6
th
 to 10
th
 standard. And 
35.2% were studied only up to 6
th
 std. Only 6.5% of the study participants 
studied up to degree. 
Table 2.Age distribution and socioeconomic status of study participants (n=108) 
Age 
group(yrs) 
Clerical % 
Skilled 
workers 
% 
Semi-
skilled 
workers 
% Total 
15-20 1 7.7% 2 15.4% 10 76.9% 13 
20-25 2 3.2% 20 32.3% 40 64.5% 62 
25-30 2 7.1% 14 50.0% 12 42.9% 28 
30-35 0 0.0% 1 20.0% 4 80.0% 5 
Total 5 4.6% 37 34.3% 66 61.1% 108 
 
Among the study participants 61.1% were semi-skilled workers, 34.3% were 
skilled workers and 4.6% clerical workers. 
Table 3.Age distribution and socioeconomic status of study participants (n=108) 
Age 
group(yrs) 
Obstetric 
formula 
0 1 2 3 4 5 
15-20 
Gravida 0 12 1 0 0 0 
Para 12 1 0 0 0 0 
Live 12 1 0 0 0 0 
Abortion 13 0 0 0 0 0 
20-25 
Gravida 0 44 12 2 3 1 
Para 48 10 4 0 0 0 
Live 50 8 4 0 0 0 
Abortion 54 7 0 0 1 0 
25-30 
Gravida 0 11 12 4 1 0 
Para 13 14 1 0 0 0 
Live 15 12 1 0 0 0 
Abortion 23 4 0 1 0 0 
30-35 
Gravida 0 2 1 1 0 1 
Para 2 2 1 0 0 0 
Live 2 3 0 0 0 0 
Abortion 3 1 1 0 0 0 
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Figure 3 and Table 2 shows the distribution of parity among study 
participants. Out of the total participants 69 presented with G1, 26 with G2, 7 
with G3, 4 with G4, and 2 with G5. Para 1 , Live1, Abortion1 were 27,24 and 12 
respectively.  
Figure 3. Distribution of gravity among study participants 
 
Table 4.Descriptive statistics of study participants profile 
Item 
Minimum Maximum Mean 
Std. 
Deviation 
Age(yrs) 18 34 24.31 3.38 
Height(cms) 150 170 158.29 5.52 
Weight(kg) 49 75 62.90 7.78 
Gravida 1 5 1.56 0.91 
Para 0 2 0.36 0.59 
Live 0 2 0.31 0.56 
Abortion 0 4 0.19 0.59 
Gestational 
Age(weeks) 
32 36 34.70 1.23 
 
The mean age of study participants was 24.31 years (SD: 3.38) with 95% 
Confidence Interval from 23.67 to 24.96 yrs. The average gestational weeks 
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of study participants was 34.7(SD: 1.23& 95% CI: 34.47-34.94). The mean 
height was 158.29 cms, weight 62.90 kgs. 
Membrane Rupture: 
Figure 4. Age group and pre-term PROM 
 
Figure 4. Shows the distribution of gestational week and age group of study 
participants. The maximum number of PPROM occured in the age group of 
20-25 years with 17 pregnant mother with early PPROM (32-34weeks) and 
45 with late PPROM (34-36weeks). In 15-20 years, 12 mothers presented 
with late PPROM compared with one in early PPROM. 
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Figure 5. Pre-term PROM 
 
 
The pie diagram in figure 5 shows among study participants of 80.6 %( 87) in 
late PPROM and 19.4 %( 21) in early PPROM. 
Table 5.Details of Membrane Rupture outside 
MRO Minimum Maximum Mean 
Std. 
Deviation 
MRO at 
admission(hrs) 1 77 14.91 13.828 
Admission 
Delivery 
interval(hrs) 
2 128 20.42 22.915 
MRO-
Delivery 
intervel(hrs) 
4 135 35.32 20.718 
 
Table 5. and Figure 6. Shows the membrane rupture duration at the time of 
admission, at the time of delivery and total membrane rupture duration from 
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MRO to delivery. The mean MRO during admission was 14.91 hours, 
admission to delivery interval 15.81 hours and MRO to delivery interval 
30.72 hours.  
Figure 6. Details of Membrane Rupture and delivery outcome 
 
Table 6. Details of MRO at admission 
Gestational 
age/Duration <6hrs(%) 
6-
12hrs(%) 
12-
24hrs(%) 
>24 
hrs(%) Total(%) p value 
32-34 8(38.10) 6(4.76) 1(4.76) 6(28.57) 21(100) 
0.14 
34-36 30(34.48) 20(28.74) 25(28.74) 12(13.79) 87(100) 
Total 38(35.19) 26(24.07) 26(24.07) 18(16.67) 108(100) 
 
Table 5 shows 35.19% of pregnant mothers presented with less than six hours 
of MRO with 38.1% in 32-34 weeks and 34.48% in 34-36 weeks of gestation. 
The admission after 24 hours was 16.67%. The MRO duration and the 
gestational age was not significant (p=0.14%). 
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Table 7. Details of admission to delivery duration and pre-term group 
Preterm 
Group/Admis
sion Delivery 
interval <6hrs (%) 
6-12hrs 
(%) 
12-24hrs 
(%) 
24-48hrs 
(%) 
>48hrs 
(%) 
Total 
(%) p value 
32-34 2(9.50) 2(9.50) 4(19.06) 9(42.90) 4(19.06) 21(100) 
0.007 34-36 31(35.60) 23(26.40 9(10.30) 18(10.30) 6(6.90) 87(100) 
Total 33(30.6) 25(23.1) 13(12.03) 27(25) 10(9.25) 108(100) 
  
Totally 23.1% of MRO clients delivered in 6-12 hrs of admission and 9.5% in 
32-34 weeks of gestation and 26.4% in 34-36 weeks. And 35.6% were 
delivered within six hours of admission in 34-36 weeks and 9.5% in 32-34 
weeks. Only 10.2% were delivered after 48 hours out of that 6.9% delivered 
in 34-36 weeks and 23.8% in 32-34 weeks. The difference of delivery 
duration between these two groups was statistically significant (p<0.007) 
Table 8. Details of MRO to delivery 
Preterm 
group/MRO-
Delivery 
group(hrs) <12 (%) 
12-24 
(%) 
24-48 
(%) >48 (%) 
Total 
(%) 
p 
value 
32-34 1(4.76) 3(14.29) 7(33.33) 10(47.62) 21(100) 
0.001 34-36 14(16.09) 32(36.78) 31(35.63) 10(11.49) 87(100) 
Total 15(13.89) 35(32.41) 38(35.19) 20(18.52) 108(100) 
 
In the gestational age group of 32-34 weeks, 4.76% deliveries were conducted 
from MRO to delivery duration of <12 hrs. But 16.09% were conducted in 
34-36 weeks. And 47.62% of total deliveries conducted in 32-34 weeks at 
more than 48 hours and 11.49% in 34-36 weeks. Table 7 shows the statistical 
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significant difference between early and late pre-term PROM group 
(p<0.001). 
Active and Expectant management: 
Figure 7. Management protocol for PPROM patients 
 
Among total study participants 50.9 %( 55) were given active management 
and 49.1 %( 53) given expectant management for PPROM. 
The height of 155-160 cms was high (44.00%) in active management while it 
was high in 150-155 cms in case of active management group (39.62%). The 
weight was high in 60-70kgs group both the management groups (44%). The 
age group of 20-25 years was high in expectant management (53.23%) and 
30-35 yrs group was high (80%) in active management while compare both 
the group. But in both the groups in the age group of 20-25 was high in 
numbers. (Table.9) 
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Table 9. Management option and personal attributes for PPROM (n=108) 
Attributes Characters 
Active 
management % 
Expectant 
management % Total p value 
Height 
Group(cm) 
150-155 17 44.74 21 55.26 38   
155-160 22 57.89 16 42.11 38   
160-165 7 36.84 12 63.16 19   
165-170 9 69.23 4 30.77 13 0.206 
Weight 
group(kgs) 
<50 4 50.00 4 50.00 8   
50-60 18 54.55 15 45.45 33   
60-70 
22 50.00 22 50.00 44 
  
>70 11 47.83 12 52.17 23 0.96 
Age 
groups 
15-20 8 61.54 5 38.46 13   
20-25 29 46.77 33 53.23 62   
25-30 14 50.00 14 50.00 28   
30-35 4 80.00 1 20.00 5 0.44 
Education <6th Std 21 55.26 17 44.74 38   
6th to 10th 
Std 
21 48.84 22 51.16 43 
  
10th to 
12th Std 
12 60.00 8 40.00 20 
  
Degree 1 14.29 6 85.71 7 0.19 
Socio 
Economic 
Status 
Clerical 4 80.00 1 20.00 5   
Skilled 
workers 
24 64.86 13 35.14 37 
  
Semi-
skilled 
workers 
27 40.91 39 59.09 66 0.02 
Total 
55 50.93 53 49.07 108 
  
 
The predominant age group less than 12
th
 standard lies in both the groups. 
While comparing the socio economic status between the management groups 
clerical staff were high percentage in active (80%) and semi –skilled workers 
in expectant management group. If we count individual group highest 
numbers were noted in semi-skilled group. Height, weight and age group was 
not statistically significant between active and expectant management of 
PPROM. But Socio economic status has a significant association between 
 51 
 
management groups. Clerical and skilled workers mostly put up in active and 
semiskilled workers (59%) put up in expectant management.(Table.9) 
Table 10. Relationship between hospital course in the study participants (n=108) 
Attribute
s 
Character
s 
Active 
management % 
Expectant 
managemen
t % Total p value 
MRO at 
admission 
group 
<6hrs 6 15.79 32 84.21 38 
 6-12hrs 8 30.77 18 69.23 26 
 12-24hrs 24 92.31 2 7.69 26 
 >24 hrs 17 94.44 1 5.56 18 0.000 
Admission 
Delivery 
interval 
group 
<6hrs 30 90.92 3 9.08 33 
 6-12hrs 21 84.00 4 16.00 25 
 12-24hrs 
1 0.00 12 
100.0
0 
13 
 24-48hrs 3 11.10 24 88.90 27 
 >48hrs 
0 0.00 10 
100.0
0 
10 
0.000 
MRO-
Delivery 
group(hrs) 
<12 7 46.67 8 53.33 15 
 12-24 16 45.71 19 54.29 35 
 24-48 22 57.89 16 42.11 38 
 >48 10 50.00 10 50.00 20 0.74 
Mode of 
delivery 
Labour 
Natural 
36 45.57 43 54.43 79 
 LSCS 
18 66.67 9 33.33 27 
 Forceps 
delivery 
1 50.00 1 50.00 2 
0.16 
High 
Vaginal 
Swab 
No growth 51 54.84 42 45.16 93 
 E.Coli 
3 30.00 7 70.00 10 
 Staphyloco
cus aureus 1 25.00 3 75.00 4 
 Klebsiella 
0 0.00 1 
100.0
0 
1 
0.22 
        
Total 55 50.93 53 49.07 108  
 
In MRO to admission group, highest number of persons (94.44%) got 
admitted in > 24 hrs of MRO in active management but it was highest in <6 
hrs in expectant management (84.21%) if comparing between the group.  
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Most of the patients got admitted in active management group (24) in 12-24 
hrs. Among delivered with in <6hrs after hospital admission, 90.92% in active 
and 9.08% in expectant management group. In 6-12 hrs. , it was 84% in active 
and 16 % in expectant management group. Only 11.1% got delivered more 
than 12 hrs in active management and 89.9% in expectant management.  
MRO at the time of admission and duration between admission and delivery 
were associated with active and expectant management. Total MRO to 
delivery duration, mode of delivery and vaginal growth on high vaginal swab 
does not have any association with the management options. 
Table 11. PPROM mother hospitalisation between the treatment group(n=108) 
Attributes 
Charcter
s 
Active 
manage 
-ment % 
Expectant 
manage 
-ment % Total p value 
Duration of 
Hospitilization
-Mother(Days) 
<5days 38 53.52 33 46.48 71 
 >5 days 
17 45.95 20 54.05 37 
0.45 
maternal 
puerperium 
No 
55 50.93 53 49.07 108 
 Fever No 55 51.40 52 48.60 107 
 Yes 0 0.00 1 100.00 1 1.047 
Tachycardia No 
55 50.93 53 49.07 108 
 Foul Smelling 
Vaginal 
Discharge 
No 
55 50.93 53 49.07 108 
 Abruptio 
placenta 
No 55 51.40 52 48.60 107 
 Yes 0 0 1 100.00 1 0.30 
Total 55 50.93 53 49.07 108 
  
The duration of mother stay in the hospital more than 5 days was high in 
expectant management (54.05%) than in active management (45.95%). 
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Maternal puerperium, tachycardia and foul smelling vaginal discharge were 
not present in the both the groups.  Fever was noted in one patient in 
expectant and two in active management group. Abruptio placenta was noted 
in one case in expectant management. The duration of mother hospitalization 
and post-operative complications like fever, abruption placenta were not 
statistically associated with active and expectant management (p>0.05) 
Table 12. Neonatal factors and PPROM management (n=108) 
Attributes 
Charcter
s 
Active 
manage 
-ment % 
Expectant 
manage 
-ment % Total p value 
Duration of 
Hospitalisation
-Baby(Days) 
<5days 35 63.64 20 36.36 55 
 >5 days 
20 37.74 33 62.26 53 
0.007 
Birth 
Weight(Kg) 
<1.5 0 0.00 1 100.00 1 
 1.5-2 10 29.41 24 70.59 34 
 2-2.5 29 53.70 25 46.30 54 
 >2.5 16 84.21 3 15.79 19 0.002 
Apgar Score-
1min 
<7 27 46.55 31 53.45 58 
 >7 28 56.00 22 44.00 50 0.33 
Apgar Score-
5min 
<7 11 50.00 11 50.00 22 
 >7 44 51.16 42 48.84 86 0.92 
Sepsis No 53 54.10 45 45.90 98 
 Yes 2 20.00 8 80.00 10 0.04 
RDS No 38 44.71 47 55.29 85 
 Yes 17 73.90 6 26.10 23 0.01 
LBW No 51 54.84 42 45.16 93 
 Yes 4 26.67 11 73.33 15 0.04 
Pre-maturity No 52 53.06 46 46.94 98 
 Yes 3 30.00 7 70.00 10 0.16 
Asphyxia No 53 51.96 49 48.04 102 
 Yes 2 33.33 4 66.67 6 0.38 
Hypoglycemia No 53 50.48 52 49.52 105 0.58 
Yes 2 66.67 1 33.33 3 
 Necrotising 
Entero colitis 
No 52 50.98 50 49.02 102 
 Yes 3 50.00 3 50.00 6 0.93 
Others NO 52 50.49 51 49.51 103 
 Yes 3 60.00 2 40.00 5 0.67 
Total  55 50.93 53 49.07 108  
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The duration of neonate hospitalisation was more than 5 days in 62.26% in 
expectant management and 37.74% in active management. The same was less 
than 5 days in 63.34% in active and 36.36% in expectant management. The 
difference was statistically significant (p=0.007). Low birth weight between 
1.5-2 kgs was seen high (73.33%) in expectant and 26.67% in active 
management. The birth weight between active and expectant management 
was statistically significant (p=0.002). Apgar score of 1 min and 5 min 
between the treatment groups was not statically significant. Sepsis was 
present in 20% of active and 80% of expectant management and the 
difference was statically significant. As like this RDS was also high in active 
(73.90%) than in expectant management (26.10%). The difference between 
prematurity, asphyxia, NEC and others were not statically significant between 
two treatment groups (p>0.05). 
Fig 8.Gestational week and management of PPROM 
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Figure 8.and Table13. shows the relationship between gestational age and 
active and expectant management. Active management was high in 34-36 
weeks groups (55.17%) compared with 44.83% in expectant management and 
expectant management was high 66.67% in 32-34 weeks groups than active 
management (33.33%). However these differences were not statistically 
significant (p=0.09).  
Table 13. Management of PPROM and gestational group 
Pre-term 
Group 
Active 
management 
% Expectant 
management 
% Total (%) P value 
32-34 7 33.33 14 66.67 21(100) 0.72 
34-36 48 55.17 39 44.83 87(100) 
Total 55 50.93 53 49.07 108(100) 
 
The active management was less in 32-34 weeks of PPROM (33.33%) when 
compared with expectant management (66.67%), whereas this was reversed in 
34-36 weeks of PPROM. The difference between active and expectant line of 
management between early preterm PROM and late preterm PROM was not 
statistically significant (p=0.72). 
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Table14: Oxytocin induction and management of PPROM 
 
 
 
 
Oxytocin induction was high (49) in active management than in expectant 
management (6) and these difference was highly significant statistically 
(p<0.001). 
Table15. Relationship PGE induction and management of PPROM 
Management  
PGE induction 
p value 
No Yes  Total 
Active 
management 
52 3 55 
 
0.08 
 
Expectant 
management 
53 0 53 
Total 105 3 108 
 
Only three patients were given PGE-2 gel for induction in active management 
and none were given in expectant management. 
 
 
Management 
Oxytocin induction 
p value No Yes Total 
Active 
management 6 49 55 
 
0.001 
 
Expectant 
management 47 6 53 
Total 53 54 108 
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Table 16. Mother hospitalization  in the management groups based on mode of 
delivery(n=108) 
  
Management 
  
MOD 
Duration of 
Hospitilisation-
Mother(Days) 
Total 
  
p value <5days 
>5 
days 
Active 
management 
Labour 
Natural 
34 2 36 
0.00 
LSCS 
3 15 18 
Forceps 
delivery 1 0 1 
  38 17 55 
 Expectant 
management 
Labour 
Natural 
32 11 43 
0.00 
LSCS 
0 9 9 
Forceps 
delivery 1 0 1 
  
33 20 53 
 
The number of study participants who stayed less than 5 days in the hospital 
was high then >5 days in labour naturals and forceps delivery and it was 
reversed in case of LSCS. .Duration of hospitalisation of mother was highly 
statistically significant in relation with mode of delivery in both the 
management group(p<0.001) 
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Table 17. Hospitalisation of baby and the management group based on mode of 
delivery (n=108) 
  
Management 
  
Duration of 
Hospitilisation-
baby(Days) 
Total 
  
p value MOD 
0-
5days 
>5 
days 
Active 
management 
Labour 
Natural 23 13 36 
0.73 
LSCS 
11 7 18 
Forceps 
delivery 
1 0 1 
 Total 
35 20 55 
 Expectant 
management 
Labour 
Natural 
29 14 43 
0.18 
LSCS 
5 4 9 
Forceps 
delivery 1 0 1 
 Total 35 18 53 
 
Table 17. describes the duration of stay in both the study groups in relation 
with mode of delivery. Duration of hospitalisation of baby was not 
statistically significant in relation with mode of delivery in both the 
management group (p<0.73 in active management group and 0.18 in 
expectant management. 
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Table 18. Duration of stay of study participants in Labour naturals (n=79) 
Management 
Number of 
participants Mean(days) SD P value 
Active 
management 
36 3.61 
 
 
1.05 
0.00 
Expectant 
management 
43 5.14 1.06 
 
The time duration of stay among pregnant put up in the active management 
was 3.61days and in expectant management 5.14 days in the hospital. The 
mean difference of hospitalisation between active and expectant management 
was highly significant in patients delivered labour naturals (p<0.001). 
Table 19. Duration of stay of study participants undergone LSCS (n=27) 
Management 
Number of 
participants Mean(days) SD P value 
Active 
management 
18 7.67 
 
 
2.08 
0.00 
Expectant 
management 
9 10.44 2.12 
 
The mean duration of stay in the hospital among pregnant mother undergone 
LSCS in active management was 7.67 days compared to 10.44 days in 
expectant management. The mean difference of hospital stay of mother 
between active and expectant management was highly significant in patients 
delivered by LSCS (p<0.001). 
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Table 20. Duration of hospital stay in admitted neonates (n=68) 
Management 
Number of 
participants Mean(days) SD P value 
Active 
management 
31 7.10 
 
 
3.04 
0.90 
Expectant 
management 
37 8.49 3.15 
 
Among admitted children, the mean duration of hospital stay in active 
management was 7.10 days and in expectant management 8.49 days. The 
mean difference of hospital stay of infant born between active and expectant 
management was not significant (p<0.90). 
 
Figure 9. Indication for LSCS in the study participants 
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The indication for Caesarean section is given in Figure 9. The reasons were 
oligohydraminios, fetal distress, failure to progress and breech presentation 
with oligohydraminios in reducing order. 
Table 21.Univariate analysis of management of PPROM (n=108) 
                   Factors 
Active 
management 
Expectant 
management 
P 
value 
Mean(SD) Mean(SD) 
Age(yrs) 24.30(3.67) 24.32(3.09) 0.26 
Gestational Age(weeks) 35.15(1.15) 34.25(1.16) 0.90 
Gravida 1.55(0.83) 1.57(0.99) 0.77 
Para 0.35(0.55) 0.38(0.63) 0.39 
Live 0.33(0.55) 0.30(0.57) 0.88 
Abortion 0.20(0.52) 0.19(0.65) 0.99 
MRO at admission (hrs) 22.25(15.02) 7.28(6.55) 0.00 
Admission Delivery interval (hrs) 9.29(17.26) 31.96(22.45) 0.00 
MRO-Delivery interval (hrs) 31.55(22.34) 39.25(23.18) 0.82 
Duration of Hospitalisation of 
Mother(days) 4.96(2.40) 6.04(2.38) 0.12 
Duration of Hospitalisation of 
Baby(days) 4.00(4.22) 5.92(4.90) 0.69 
Apgar Score-1min 6.07(1.40) 6.04(1.43) 0.87 
Apgar Score-5min 7.35(1.16) 7.38(1.18) 0.89 
 
Univariate analysis was done for important factors that determine the 
management of PPROM (Table.21). The mean age of patients put in active 
management was 24.30 years (SD: 1.15) and 24.32 years in expectant 
management group. Average gravida, para, live, abortion in active 
management group was 1.55, 0.35, 0.33 and 0.20 and expectant management 
1.57, 0.38, 0.30 and 0.19 respectively. The mean time after MRO for 
admission was high in active management (22.25 hrs) than in expectant 
management (7.28 hrs). But the time duration between admission and delivery 
 62 
 
was reversed; it was high in expectant management (Mean: 31.96hrs) 
compared with active management. The mean time duration between MRO to 
delivery duration in active management was 31.55 hrs and expectant 
management 39.25 hrs. In that MRO time during admission and time duration 
between admission and delivery were highly significant. But the obstetric 
parity, gestational age, age of the patients, duration of hospitalization of baby 
and mother and apgar 1and 5 min. were not statistically significant between 
treatment groups.  
Table 22. Profile of hospitalized neonates (n=68) 
Attributes Characters 
Active 
management 
% 
Expectant 
management 
% Total 
p 
value 
Duration of 
hospitalisation-
Baby(Days) 
<5days 11 73.3 4 99.26 15 
0.02 >5 days 20 37.7 23 99.62 53 
Birth 
Weight(Kg) 
<1.5 0 0 1 100 1 
0.01 
1.5-2 8 26.7 22 73.3 30 
2-2.5 18 56.3 14 43.7 32 
>2.5 5 100 0 0 5 
Apgar Score-
1min 
<7 18 43.9 23 56.1 41 
0.86 >7 13 48.1 14 51.9 27 
Apgar Score-
5min 
<7 8 47.1 9 52.9 17 
0.55 >7 23 45.1 28 54.9 51 
Sepsis Yes 2 25 6 75 8 1.95 
RDS Yes 17 73.9 6 26.1 23 0.00 
LBW Yes 3 23.1 10 76.9 13 0.07 
Pre-maturity Yes 3 30 7 70 10 0.32 
Asphyxia Yes 2 33.3 4 66.7 6 0.52 
Hypoglycaemia Yes 2 66.7 1 33.3 3 0.58 
Necrotising 
Entero colitis 
Yes 3 50.1 3 49.9 6 
1.00 
Others Yes 3 60 2 40 5 0.65 
Total 
  
31 45.6 37 54.4 68 
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Babies‟ duration of hospitalisation whose were born from active and 
expectant management was not statistically significant. As like RDS, birth 
weight was also statistically significant. 
Table 23.Profile of hospitalization based upon preterm group(n=68) 
Pre-
term 
grou
p 
Attributes 
Charact
ers 
Active 
management 
% 
Expectant 
management 
% Total p value 
32-34 
Duration of 
hospitalisation-
Baby(Days) 
<5days 2 100 0 0.0 2 
0.03 
>5 days 5 26.3 14 74.7 19 
34-36 
Duration of 
hospitalisation-
Baby(Days) 
<5days 9 69.2 4 30.8 13 
0.12 
>5 days 15 44.1 19 55.9 34 
32-34 
Birth 
Weight(Kg) 
<1.5 0 0 1 100.0 1 
0.93 1.5-2 5 27.8 13 72.2 18 
2-2.5 2 100 0 0.0 2 
>2.5 0 0 0 0.0 0 
34-36 
Birth 
Weight(Kg) 
<1.5 0 0 0 0.0 0 
0.17 
1.5-2 3 25 9 75.0 12 
2-2.5 16 53.3 14 46.7 30 
>2.5 5 100 0 0.0 5 
32-34 
Apgar Score-
1min 
<7 5 33.3 10 66.7 15 
1.00 
>7 2 33.3 14 66.7 16 
34-36 
Apgar Score-
1min 
<7 13 50 13 50.0 26 
1.00 
>7 11 52.4 10 47.6 21 
32-34 
Apgar Score-
5min 
<7 2 40 3 60.0 5 
1.00 
>7 5 31.3 11 68.7 16 
34-36 
Apgar Score-
5min 
<7 6 50 6 50.0 12 
1.00 
>7 18 51.4 17 48.6 35 
32-34 Sepsis Yes 1 20.00 4 80.0 5 0.12 
34-36 Sepsis Yes 1 33.3 2 66.7 3 1.00 
32-34 RDS Yes 5 83.3 1 16.7 6 0.01 
34-36 RDS Yes 12 70.6 5 29.4 17 0.07 
32-34 LBW Yes 3 42.9 4 57.1 7 0.63 
34-36 LBW Yes 0 0 6 100.0 6 0.00 
32-34 Pre-maturity Yes 1 20 4 80.0 5 0.62 
34-36 Pre-maturity Yes 2 40 3 60.0 5 0.66 
32-34 Asphyxia Yes 0 0 2 100.0 2 0.53 
34-36 Asphyxia Yes 2 50 2 50.0 4 1.00 
32-34 Hypoglycaemia Yes 1 50 1 50.0 2 1.00 
34-36 Hypoglycaemia Yes 1 100 0 0.0 1 1.00 
34-36 
Necrotising 
Entero colitis 
Yes 3 50 3 50.0 6 1.00 
32-34 Others Yes 0 0 1 100.0 1 1.00 
34-36 Others Yes 3 75 1 25.0 4 0.69 
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Duration of hospitalisation of baby was significant between treatment group 
in 32-34 weeks (p<0.03). But it was not statistically significant in 34-36 
weeks group. LBW was significant in 34-36 weeks group between two 
management group (p<0.001). Remaining other indicators was not significant 
between treatment groups in both preterm groups. 
Table 24. PPROM Mother and pre term division (n=108) 
Pre-
term 
group 
Attributes Characters 
Active 
management 
% 
Expectant 
management 
% Total 
p 
value 
32-34 
Admission 
Delivery 
interval 
<6hrs 2 100.00 0 0.00 2.00 
0.03 
6-12hrs 2 100.00 0 0.00 2.00 
12-24hrs 1 25.00 3 75.00 4.00 
24-48hrs 2 22.22 7 77.78 9.00 
>48hrs 0 00.00 4 100.00 4.00 
34-36 
Admission 
Delivery 
interval 
<6hrs 28 90.32 3 9.68 31.00 
0.00 
6-12hrs 19 82.61 4 17.39 23.00 
12-24hrs 0 0.00 9 100.00 9.00 
24-48hrs 1 5.56 17 94.44 18.00 
>48hrs 0 0.00 6 100.00 6.00 
32-34 
Mode of 
delivery 
Labour 
Natural 6 31.58 13 68.42 19.00 
1.00 LSCS 1 50.00 1 50.00 2.00 
34-36 
Mode of 
delivery 
Labour 
Natural 30 50.00 30 50.00 60.00 
0.31 
  LSCS 17 68.00 8 32.00 25.00 
  
Forceps 
delivery 1 50.00 1 50.00 2.00 
32-34 
Duration of 
Hospitalization-
Mother(Days) 
<5days 5 33.33 10 66.67 15.00 
1.00 
>5 days 
2 33.33 4 66.67 6.00 
34-36 
Duration of 
Hospitalization-
Mother(Days) 
<5days 33 58.93 23 41.07 56.00 
0.37 
>5 days 
15 48.39 16 51.61 31.00 
34-36 Fever Yes 0 0.00 1 100.00 1.00 0.00 
32-34 
Abruptio- 
Placenta 
Yes 
0 0.00 1 100.00 1.00 0.46 
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Admission delivery interval was significant in both 32-34 as well as 34-36 
weeks preterm PPROM. Mode of delivery, duration of hospitalisation of 
mother, fever and abruptio placenta were not significant between management 
in both preterm group. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
DISCUSSION 
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Discussion 
Among the participants studied for preterm premature rupture of membranes 
over a period of one year  has shown that the incidence of PPROM is more 
common in younger age group  of 20-25 years (57%) and less in > 30 years 
(5%). The same results were noted in study by shehla et al where the 
incidence of PPROM in women < 25 years was 58.8%.
27 
The incidence of 
PPROM is more common in low socio economic group of 61.1% in our study 
which is similar to the study by shehla et al is 68.2%.
27
 The high prevalence 
in younger age and low socio economic group is due to early marriages and 
poverty leading to poor nutrition which is one of the risk factor for PPROM. 
The incidence of PPROM was 3.56% in our study. The PPROM incidence is 
stated between 4-14%
15 
in various studies. The low incidence of PPROM is 
due to regular antenatal check-ups, increased living condition and wide use of 
antibiotics. 
In present study there is no significant difference observed between the 
distribution of gravida, Para, live and abortion in both active and expectant 
management. 
Around 85% of patients in both groups are admitted within 24 hours of 
membrane rupture in the study. In PPROM, most of the patients get into 
labour within few hours. In PPROM labour generally occurs within 24 hours 
in 35-50 % , within 72 hours in 70 %, and 90% of patients will deliver within 
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two weeks (Daftary et al).
72
 In the present study, in expectant group out of the 
53 patients 19 patients (35.84%) were delivered within 24 hours and 10 (18 
%) patients have the latency period of > 48 hours . A study by Neerhof et al 
shows that only 10% of the women managed expectantly had latency period 
greater than 48 hours.
67
 In active management group, about 52 (94%) of 
patients delivered within 24 hours. This is due to the augmentation of labour 
by oxytocin and PGE2 gel in active management group. 
The incidence of  LSCS in active management is 32.12 %  whereas in 
expectant group is 16.9%.In the study by Naef et el the incidence of LSCS in 
both groups are equal.
66
 There was only one forceps delivery in  both active 
group and conservative group. 
 
The incidence of chorioamnionitis is 5.6% (3 patients) in conservative group 
and none in active group whereas the incidence of chorioamnionitis is 2% in 
active group and 16% in expectant group in the study by Naef et al.
66
 The 
decrease in incidence was probably due to prophylactic antibiotics usage. 
The mean duration of hospitalisation in active management group is 3.61 in 
labour natural and 7.67 in LSCS whereas in expectant group is 5.14 in labour 
natural and 10.44 in LSCS. The duration of hospitalisation is prolonged in 
expectant group in our study which is due to prolonged latency period. 
Mercer et al also reported prolonged hospitalisation of mothers in expectant 
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group managed between 32 to 36 weeks.
65
 There was one (1.8%) reported 
case of abruption and one (1.8%) case of puerperal fever in expectant group. 
There was no reported case of puerperal sepsis or post-partum endometritis. 
 
The incidence of growth in high vaginal swab culture in active management 
was 7.2% and 20% in expectant management however this difference was not 
statistically significant. E-coli was identified in 9.25% of high vaginal swabs 
in our study. A case control study conducted in Mysore showed a high 
incidence of E.coli (20 %) and confirmed the association between E.coli 
infections in PPROM .
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 These culture positive patients were treated with 
antibiotics according to antibiotic sensitivity test results. 
 
The mean duration of hospitalisation of new born was 7.10 days in active 
management and   in expectant management 8.49 days which is statistically 
significant. There was no significant difference in 1minute and 5 minutes 
Apgar score in both the groups. In the study by Naef et al, shows that there is 
no significant difference in hospital stay in both groups.
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 The incidence of 
RDS was high in active (73.90%) than in expectant management (26.10%) 
whereas the incidence of sepsis is 80% in expectant and 20% in active 
management. The incidence of Low birth weight is 70.59% in expectant 
group whereas it is 29.41% in active group which is not statistically 
significant. Even though there is increased incidence of hospitalisation in both 
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the groups there was no neonatal mortality. This is due to the early detection 
of the complications and timely intervention and appropriate treatment. 
 
In the present study in 32 to 33 weeks 6 days group 7 patients (33.33%) were 
put in active group and 14 patients (66.66%) were put in expectant 
management. About 22.22% and 77.77% were delivered within 48 hours in 
active and expectant management respectively which is statistically 
significant. The maximum admission –delivery in this group was 128 hours. 
There was only one reported case of chorioamnionitis in expectant 
management. In 34 to 36 weeks 6 days also the admission –delivery interval 
in both modes of management were statistically significant. In the view of 
admission –delivery interval in both the groups, expectant management is the 
suggested method in 32 to 33 weeks 6 days group and active management is 
the suggested method in 34 to 36 weeks 6 days group. The mode of delivery, 
duration of hospitalisation the incidence of fever and abruptio placenta was 
not statistically significant in both the groups.  
 
In the analysis of admitted babies the duration of hospitalisation of newborn   
for more than 5 days were 26.3 % and 74.7% in active and expectant 
management in   32 to 33 weeks 6 days group which is statistically 
significant. Whereas the duration of newborn hospitalisation in 34 to 36 
weeks 6 days group in both modes of management is not statistically 
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significant. The incidence of RDS was 83.3% in active and 16.7% in 
expectant group in 32  to 33 weeks 6 which is statistically significant whereas 
in 34  to 36 weeks 6 days group RDS incidence was 70.6% and 29 .4% in 
active and expectant group which is not statistically significant. The incidence 
of sepsis, prematurity and other neonatal complications in both the groups and 
both modes of management were not statistically significant. Overall there is 
increased adverse outcomes were noted in active management in 32 to 33 
weeks 6 days. However in 34 to 36 weeks 6 days there was no significant 
hospitalisation and the neonatal outcome in both mode of management was 
similar .so when considering the maternal factors in active and expectant 
management in this group, there is no added advantage of expectant 
management in 34 to 36 weeks 6 days in this study. In the study by Neerof et 
al also suggested that there needs a natural break point at 34 weeks of 
gestation in the mode of management in preterm premature rupture of 
membranes between 32 and 36 completed  weeks pertaining to the view of  
neonatal morbidity.
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Summary 
PPROM is preterm premature rupture of membranes that occur before 
initiation of labour and before term. This alters the normal labour process and 
leads to wide range of complication in mother as well as foetus and the 
neonate after delivery. Hence a prospective comparative study was conducted 
to find out the incidence of PPROM, examine the various modes of the 
treatment options and study the maternal and fetal outcome. 
This study was conducted in Govt. Kasturba Hospital, Triplicane, Madras 
Medical College, Chennai in the period of December2012 to November 2013. 
Pregnant women with gestational week of 32-36 completed weeks (37 weeks) 
with confirmed ROM, Singleton pregnancy, Primi and multigravida in the age 
group between 15-35 years were included and multiple pregnancies with 
severe complications were excluded. Sample size was calculated to 108 by 
using 7.72% prevalence of PPROM and 5% precision. 
Study participants were included randomly in active and expectant 
management groups. The admission, management procedures and events 
during delivery and puerperium and neonatal outcome were studied. 
Statistical analysis was done using SPSS version 12. Proportion, 
nonparametric test and independent sample„t‟ test were used. Ethical 
committee approval was obtained from Institutional Ethics Committee from 
Madras Medical College.  
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The incidence of PPROM was 3.56%. It was high in 34-36 weeks of 
gestation. And 55 clients were put up in active management and 53 in 
expectant management. The majority of the study participants were in the age 
group of 20-25yeras (57%). And 26% were in the age group of 25-30 years. 
Most of the study participants (39.8%) were studied 6
th
 to 10
th
 standard. 
Among the study participants 61.1% were semi-skilled workers. Primigravida 
were 69 in number. The average gestational weeks of study participants was 
34.7(SD: 1.23 & 95% CI:34.47-34.94). 
The mean MRO duration during admission was 14.91 hours, admission to 
delivery interval 15.81 hours and MRO to delivery interval 30.72 hours. 
Height, weight and age group was not statistically significant between active 
and expectant management of PPROM. But Socio economic status has a 
significant association between management groups.  
The highest number of mothers (94.44%) got admitted in > 24 hrs of MRO 
but it was highest in <6 hrs in expectant management if comparing between 
the group. Among delivered with in < 6hrs after hospital admission, 88.24% 
in active and 11.76% in expectant management group. These differences were 
statistically significant. E-coli was identified in 9.25% of high vaginal swabs. 
Oxytocin induction was high (49) in active management than in expectant 
management (6). Only three patients were given PGE-2 gel for induction in 
active management.  
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The duration of mother stay in the hospital more than 5 days was high in 
expectant management (54.05%) than in active management (45.95%). The 
duration of mother hospitalization and post-operative complications like 
fever, abruption placenta were not statistically associated with active and 
expectant management (p>0.05). 
The duration of neonate hospitalisation was more than 5 days in 62.26% in 
expectant management and 37.74% in active management. The same was less 
than 5 days in 63.34% in active and 36.36% in expectant management. The 
difference was statistically significant (p=0.007). Apgar score of 1 min and 5 
min between the treatment groups was not statically significant.  
In the 32- 33 weeks 6 days completed group, among the study participants in 
both modes of management the admission – delivery interval is statistically 
significant. The duration of   neonate hospitalisation and the incidence of 
RDS in both modes of management are also statistically significant. Though 
the incidence of sepsis is more, it is not statistically significant. This shows 
that PPROM patients in 32- 33 weeks 6 days completed group can be put in 
expectant line of management. 
In the 34 to 36 weeks 6 days group the admission –delivery interval in both 
modes of management were statistically significant. The duration of newborn 
hospitalisation in 34 to 36 weeks 6 days group in both modes of management 
is not statistically significant. The neonatal outcomes in both modes of 
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management were not statistically significant. So when considering the 
maternal factors and fetal condition these patients can be put in active line of 
management. 
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Conclusion 
PROM is not uncommon in pregnancy. The incidence of PPROM was 3.56% 
in our study. It is common in lower socio economic status and 20-25 years of 
pregnant women. The management of PPROM depends upon the time of 
admission after MRO, clinical condition of fetus and mother and the 
gestational age of the mother. The delay in mother admission after MRO 
increases the chances of maternal and neonatal outcomes and determines the 
line of management. 
Expectant management is the suggested management in PPROM patients with 
gestational age of 32-33weeks 6 days and active line of management is for 
34-36 weeks 6 days. Also conversion from expectant to active management is 
also considered based upon maternal and fetal conditions. This will reduce the 
the neonatal complications and duration of hospitalisation. So better 
„Rooming in” is also possible. 
The respiratory distress syndrome, LBW and sepsis are major complication of 
PPROM in preterm babies and the maternal complication was less evident in 
both the treatment groups. Case control studies are suggested to find out the 
causes for PPROM. So it provides chances to prevent PPROM in future. 
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                                                              ANNEXURE-I 
 
PROFORMA 
Name: 
Age; 
Ip no: 
Educational status: 
Income:           occupation: SE status: 
DoA:                                     ToA: 
LMP: 
EDD: 
Scan EDD                                      GA(LMP/ Scan); 
Ht: 
Wt:                                                   BMI: 
Admitted for 
Men h/o: 
Mar h/o: 
Obs h/o: 
Past h/o: 
Examination:  
Temp: 
 ii 
 
Pulse: 
BP: 
CVS: 
RS: 
Abdomen 
Speculam: 
Nitrazine paper test: 
Fern test; 
Vaginal: 
 Hb: 
Total count: 
Differential count: 
ESR: 
Urine alb/sugar: 
Bd g/t: 
HIV: 
VDRL: 
High vaginal swab:  
USG: 
CTG: 
Drugs: 
 iii 
 
Mode of management: 
Mode of onset: 
Date of Delivery: 
Time of Delivery: 
Mode of delivery: 
Signs of chorioamnionitis 
If c/s ind: 
Baby weight: 
Apgar score: 
NICU admission if any ind and durationof stay; 
Post op/post natal period: 
DoD: 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 iv 
 
Annexure-II                                                                                            Master Chart 
SN Name
Ag
e IP NO Gra
par
a live
Abo
rtio
n DOA TOA LMP EDD GA
Clinic
al GA
USG 
GA Mng
HV
S Ht WT Edu SE
MRO 
admc
ont
Durati
on 
MRO
Oxyto
cin ind
Venkateswari 24 15745 1 0 0 0 30.9.13 5pm 25.1.13 2.11.13 35 34 35 Act 0 152 56 3 3 36 4 1
2 Chitra 23 17749 1 0 0 0 2.10.13 8.35pm 20.1.13 27.10.13 36 36 36 Exp 0 150 69 3 5 11 2 0
3 Meena 28 15366 1 0 0 0 29.8.13 11.36am 20.12.13 27.9.13 36 36 36 Exp 0 163 67 2 4 4 1 0
4 Nazeema begam 25 15130 1 0 0 0 26.8.13 1.15pm 4.12.12 11.9.13 36 36 36 Act 0 158 58 2 4 31 4 0
5 Nathiya 28 14885 1 0 0 0 22.8.13 8.50am 23.12.12 20.9.13 35 35 35 Exp 0 155 70 4 5 6 1 0
6 Ali Fathima 23 15192 2 1 1 0 26.8.13 2am 26.12.12 2.10.13 34 34 34 Exp 0 160 58 1 5 6 1 0
7 Pavithra 20 15884 1 0 0 0 5.9.13 5.50pm 24.12.12 30.9.13 36 36 36 Exp 0 159 52 4 5 8 2 1
8 Anandavalli 27 14367 1 0 0 0 30.8.13 9am 17.12.12 24.9.13 36 36 36 Act 0 167 73 3 4 4 1 1
9 Mahalakshmi 27 15817 1 0 0 0 4.9.13 1.30pm 27.12.13 4.10.13 36 36 36 Act 0 158 67 3 5 10 2 1
10 Meena 25 17933 4 2 2 1 4.10.13 9.45pm 30.1.13 7.11.13 36 36 36 Act 1 151 53 3 5 7 2 1
11 Poonam 20 18064 1 0 0 0 7.10.13 12.10am 5.2.13 12.11.13 36 36 36 Act 0 165 69 4 4 5 1 1
12 Kalaimani 26 17980 3 1 1 1 6.10.13 5pm 13.2.13 20.11.13 35 35 35 Act 0 157 75 2 4 37 4 1
13 Devikala 23 15568 1 0 0 0 1.9.13 2am 22.12.13 29.9.13 36 36 36 Act 0 159 61 3 5 28 4 1
14 Nithya 20 15992 1 0 0 0 7.9.13 3pm 5.1.13 12.10.13 35 35 35 Act 0 150 56 2 3 24 3 1
15 Monika 24 15621 1 0 0 0 30.9.13 5.30pm 21.2.13 28.11.13 33 33 33 Exp 0 168 51 2 5 12 2 0
16 Roseline malar 25 14421 1 0 0 0 27.9.13 6am 15.12.12 22.10.13 36 36 36 Act 2 156 75 1 5 18 3 1
17 Bhuvaneswari 29 15681 1 0 0 0 4.9.13 5pm 9.1.13 17.10.13 34 34 34 Exp 0 150 74 3 4 5 1 0
18 sivagami 22 15938 1 0 0 0 6.9.13 10am 1.1.13 8.10.13 36 36 36 Act 0 164 49 3 5 3 1 1
19 Kalaiarasi 20 16023 1 0 0 0 7.9.13 9pm 28.12.12 6.10.13 36 36 36 Act 0 164 64 3 5 7 2 1
20 Parveen 25 16005 1 0 0 0 8.9.13 1am 13.1.13 20.10.13 34 34 34 Exp 0 159 70 2 5 1 1 0
21 Lakshmidevi 26 16046 4 0 0 3 8.9.13 2am 5.9.13 16.10.13 35 35 35 Act 0 166 57 2 4 12 2 1
22 Deepa 22 15963 2 1 1 0 9.9.13 6.15pm 21.1.13 28.10.13 33 33 33 Exp 0 153 74 1 5 4 1 0
23 Dhara 21 16266 1 0 0 0 22.9.13 8.30am 15.1.13 22.10.13 36 36 36 Act 1 157 58 1 5 9 2 1
24 Leela 24 16506 1 0 0 0 26.9.13 2,55pm 24.1.13 31.10.13 35 35 35 Exp 0 162 68 4 4 2 1 0
25 Mejina banu 22 17145 2 1 1 0 24.9.13 7.15am 20.1.13 27.10.13 36 36 36 Act 0 169 54 3 5 4 1 1
26 Anandalakshmi 24 14548 1 0 0 0 16.8.13 9.20pm 24.12.12 1.10.13 33 33 33 Exp 0 154 50 2 5 2 1 1
27 Banu 32 14560 5 2 1 2 17.8.13 10.15am 15.12.12 22.9.13 34 34 34 Exp 0 153 72 2 5 12 2 0  
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1 0 1.10.13 1.50am 2 1 0 3 0 2 4 2 7 8 0 0 0 0 0 0 0 0 0 0 0 0 0 0
2 0 3.10.13 11.45pm 0 2 4 10 0 1 5 4 5 6 0 0 0 0 0 0 0 0 0 0 0 0 0 0
3 0 29.8.13 2.50pm 0 1 0 5 0 2 5 4 7 8 0 0 0 0 0 0 0 0 0 0 0 0 0 0
4 1 26.8.13 7.30pm 0 1 0 3 0 1 5 2 7 8 0 0 0 0 0 0 0 0 0 0 0 0 0 0
5 0 22.8.13 5.30pm 0 1 0 5 0 1 4 3 6 8 0 0 0 0 0 0 0 0 0 0 0 0 0 0
6 0 27.8.13 4.07pm 0 1 0 6 7 1 3 3 4 6 0 1 0 0 0 0 0 0 0 0 0 0 0 0
7 0 5.9.13 10.30pm 1 1 0 5 0 1 5 2 6 7 0 0 0 0 0 0 0 0 0 0 0 0 0 0
8 0 30.8.13 11.30am 1 1 0 3 3 2 5 4 6 7 0 1 0 0 0 0 0 0 0 0 0 0 0 0
9 0 4.9.13 7pm 1 2 4 9 0 2 5 4 8 9 0 0 0 0 0 0 0 0 0 0 0 0 0 0
10 0 5.10.13 12.15am 1 1 0 3 5 2 5 4 6 7 0 0 0 0 0 0 0 1 0 0 0 0 0 0
11 0 7.10.13 5.30am 1 1 0 3 0 1 5 3 6 8 0 0 0 0 0 0 0 0 0 0 0 0 0 0
12 1 7.10.13 11pm 1 2 4 8 5 1 5 3 7 8 0 0 0 0 0 0 1 0 0 0 0 0 0 0
13 0 1.9.13 6.30am 1 2 2 8 7 1 5 3 7 8 0 1 0 0 0 0 0 0 0 0 0 0 0 0
14 0 7.9.13 8.15pm 1 2 2 3 5 1 4 3 6 8 0 1 0 0 0 0 0 0 0 0 0 0 0 0
15 0 1.10.13 9am 0 1 0 5 8 1 2 2 6 7 0 0 0 0 0 1 0 0 0 0 0 0 0 0
16 0 27.9.13 4pm 1 2 4 4 7 2 5 3 6 7 0 1 0 0 0 0 0 0 0 0 0 0 0 0
17 0 5.9.13 4pm 0 1 0 5 8 1 2 2 4 6 0 0 1 0 0 0 0 0 0 0 0 0 0 0
18 0 6.9.13 2pm 1 1 0 4 0 1 5 4 7 8 0 0 0 0 0 0 0 0 0 0 0 0 0 0
19 0 8.9.13 4.45am 2 1 0 4 0 2 5 3 6 7 0 0 0 0 0 0 0 0 0 0 0 0 0 0
20 0 8.9.13 7am 0 1 0 4 0 2 3 3 7 8 0 0 0 0 0 0 0 0 0 0 0 0 0 0
21 0 8.9.13 12pm 1 2 2 3 3 2 3 3 7 8 0 0 0 0 0 0 0 1 0 0 0 0 0 0
22 0 10.9.13 6pm 0 1 0 5 6 1 3 2 6 8 1 0 0 0 0 0 0 0 0 0 0 0 0 0
23 0 22.9.13 1.45pm 1 1 0 4 0 2 5 4 7 8 0 0 0 0 0 0 0 0 0 0 0 0 0 0
24 0 26.9.13 11.10pm 0 2 2 9 0 2 4 3 7 8 0 0 0 0 0 0 0 0 0 0 0 0 0 0
25 0 24.9.13 4pm 2 1 0 3 0 1 5 3 7 8 0 0 0 0 0 0 0 0 0 0 0 0 0 0
26 0 17.8.13 11.30pm 1 1 0 4 9 2 2 2 6 7 0 0 0 1 0 0 0 0 0 0 0 0 0 1
27 0 17.8.13 6pm 1 1 0 6 7 2 3 3 6 7 0 1 0 0 0 0 0 0 0 0 0 0 0 0  
 vi 
 
SN Name
Ag
e IP NO Gra
par
a live
Abo
rtio
n DOA TOA LMP EDD GA
Clinic
al GA
USG 
GA Mng
HV
S Ht WT Edu SE
MRO 
admc
ont
Durati
on 
MRO
Oxyto
cin ind
28 Gayathri 25 14579 1 0 0 0 17.8.13 6.15pm 3.12.12 10.9.13 35 35 35 Exp 0 161 60 2 5 3 1 0
29 Amudha 25 14826 4 2 2 1 20.8.13 11.30.pm 5.1.13 12.10.13 33 33 33 Exp 1 169 62 3 5 10 2 0
30 Inbarasi 22 14672 1 0 0 0 22.8.13 1pm 25.12.12 2.10.13 34 34 34 Exp 0 157 65 4 4 3 1 0
31 Kowsar 22 14882 2 1 1 0 26.8.13 11pm 20.12.12 27.9.13 36 36 36 Act 0 155 50 1 4 10 2 1
32 kanimozhi 20 15066 1 0 0 0 25.8.13 3am 25.12.13 1.10.13 35 35 35 Exp 0 168 60 2 5 4 1 0
33 Adhilakshmi 27 15474 2 1 0 0 29.8.13 10pm 8.1.13 15.10.13 34 34 34 Exp 0 156 51 1 3 4 1 0
34 Dhavamani 25 4662 2 0 0 1 5.2.13 11.10am 30.5.12 7.3.13 35 35 35 Exp 1 152 70 2 5 12 2 0
35 Devika 34 16100 2 1 1 0 12.6.13 5.10.am 15.10.12 22.7.13 34 34 34 Act 0 161 52 3 5 24 3 1
36 Girija 21 16328 1 0 0 0 14.6.13 10.05am 24.10.12 31.7.13 33 33 33 Exp 1 150 67 3 4 1 1 0
37 Revathy 24 16213 1 0 0 0 16.6.13 9.25pm 5.11.12 12.8.13 32 32 32 Exp 0 153 59 4 5 12 2 0
38 sasikala 22 14318 1 0 0 0 18.6.13 5.05pm 20.10.12 27.7.13 34 34 34 Exp 0 159 72 2 5 21 3 0
39 Renuka 28 10716 2 0 0 1 20.6.13 5.45pm 30.10.12 7.8.13 33 33 33 Act 0 153 74 2 4 45 4 0
40 Sharmila 21 10956 1 0 0 0 24.6.13 9.30am 4.11.12 1.8.13 33 33 33 Exp 0 165 70 1 4 1 1 0
41 Tamizhyendhi 30 12024 1 0 0 0 25.7.13 12.25pm 28.11.12 5.9.13 34 34 34 Exp 0 164 66 1 5 1 1 0
42 Kasthuri 23 12740 1 0 0 0 27.7.13 5.35pm 14.12.12 27.9.13 32 32 32 Exp 0 160 75 2 4 9 2 0
43 Sindhu 22 11330 2 0 0 1 1.7.13 8.45pm 10.11.12 17.8.13 33 33 33 Act 0 157 63 2 5 43 4 1
44 Jayalakshmi 20 12421 1 0 0 0 8.7.13 6.15pm 12.11.12 19.8.13 34 34 34 Act 0 166 60 2 5 25 4 1
45 Thenmozhi 27 17832 2 1 1 0 3.8.13 3.40pm 7.12.12 14.9.13 34 34 34 Exp 0 150 65 2 5 11 2 0
46 Salma Afrose 21 17458 1 0 0 0 27.9.13 7.40am 16.1.13 23.10.13 36 36 36 Act 0 156 53 2 5 20 3 1
47 Rekha 21 16603 1 0 0 0 6.9.13 10.45am 2.1.13 9.10.13 35 35 35 Act 0 166 52 1 4 14 3 1
48 Rukmani 31 17543 1 0 0 0 30.9.13 10.29am 19.1.13 26.10.13 36 36 36 Act 0 153 55 1 5 10 2 1
49 Devi 23 17869 5 0 0 4 4.9.13 4.37am 14.1.13 21.10.13 33 33 33 Exp 0 160 74 2 5 44 0
50 Nandhini 32 13567 1 0 0 0 9.8.12 10.15pm 28.11.12 5.9.13 36 36 36 Act 0 157 55 1 4 2 1 1
51 Padmavathy 29 14435 2 1 1 0 23.8.13 1.12am 20.12.12 27.9.13 35 35 35 Exp 2 164 68 2 5 7 2 0
52 Anitha 22 14588 1 0 0 0 24.8.13 1.10 am 27.12.12 4.10.13 34 34 34 Exp 0 154 72 2 4 13 3 0
53 Vanitha 25 19985 1 0 0 0 1.11.12 1.15pm 28.2.12 7.12.12 35 34 35 Exp 0 155 66 2 4 1 1 1
54 Deepa 21 20029 2 1 1 0 2.11.12 7.10am 4.3.12 11.12.12 34 34 34 Exp 0 159 66 1 5 6 1 0  
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28 0 18.8.13 9 .30am 1 1 0 8 0 2 4 3 6 7 0 0 0 0 0 0 0 0 0 0 0 0 0 0
29 0 22.8.13 2.35am 0 1 0 5 9 1 2 2 4 5 0 0 0 0 0 0 0 0 0 0 0 0 0 0
30 0 22.8.13 9.15pm 0 1 0 3 7 2 3 3 6 7 1 0 0 0 0 0 0 0 0 0 0 0 0 0
31 0 27.8.13 3am 1 1 0 3 0 2 5 3 6 7 0 0 0 0 0 0 0 0 0 0 0 0 0 0
32 0 25.8.13 8:00 PM 0 1 0 5 0 1 4 3 6 7 0 0 0 0 0 0 0 0 0 0 0 0 0 0
33 0 30.8.13 11.30pm 0 1 0 6 0 2 3 3 6 7 0 0 0 0 0 0 0 0 0 0 0 0 0 0
34 0 6.2.13 3.15am 0 1 0 6 5 2 3 3 7 8 0 1 0 1 0 0 0 0 0 0 0 0 0 0
35 0 12.6.13 4.07pm 1 1 0 3 0 1 3 3 7 8 0 0 1 0 0 0 0 0 0 0 0 0 0 0
36 0 17.6.13 2.30pm 0 1 0 3 10 2 2 2 7 8 0 0 1 0 0 0 0 0 0 0 0 0 0 0
37 0 21.6.13 4.10pm 0 1 0 4 15 1 1 2 6 7 0 0 0 1 0 0 0 0 0 0 0 0 0 0
38 0 20.6.13 10.35am 0 1 0 4 4 2 3 3 8 9 0 0 0 0 0 0 0 1 0 0 0 0 0 0
39 0 21.6.13 1.15am 0 1 0 4 12 2 2 2 5 8 0 1 0 0 0 0 0 0 0 0 0 0 0 0
40 0 25.6.13 4.15pm 0 1 0 6 7 1 2 2 8 9 0 1 0 1 0 0 0 0 0 0 0 0 0 1
41 0 27.7.13 6.45am 0 1 0 5 8 1 3 2 8 9 0 0 0 0 0 0 0 0 0 0 0 0 0 0
42 0 28.7.13 8.30pm 0 1 0 6 12 2 1 1 5 8 0 0 0 1 0 0 0 0 0 0 0 0 0 0
43 0 2.7.13 2.10am 0 1 0 3 15 2 2 2 7 8 0 0 1 0 0 0 0 0 0 0 0 0 0 0
44 0 9.7.13 1,05am 2 2 1 9 8 1 3 2 8 9 0 1 0 0 0 0 0 0 0 0 0 0 0 0
45 0 4.8.13 6.22pm 0 1 0 4 7 1 3 2 5 7 0 0 0 0 0 0 0 0 0 0 0 0 0 0
46 1 27.9.13 1.05pm 2 2 4 9 0 2 5 3 6 7 0 0 0 0 0 0 0 0 0 0 0 0 0 0
47 0 6.9.13 5.15pm 2 2 1 9 0 1 4 3 7 8 0 0 0 0 0 0 0 0 0 0 0 0 0 0
48 0 30.9.13 1.45pm 1 2 4 9 0 2 5 4 6 8 0 0 0 0 0 0 0 0 0 0 0 0 0 0
49 0 5.9.13 12.05am 0 2 2 10 13 2 2 2 6 7 0 0 1 0 0 0 0 0 0 0 0 0 0 0
50 0 10.8.13 2.35am 1 1 0 3 4 1 5 3 3 5 0 1 0 0 0 0 0 0 0 0 0 0 0 0
51 0 24.8.13 11.35pm 0 3 0 5 0 2 4 3 6 8 0 0 1 0 0 0 0 0 0 0 0 0 0 0
52 0 26.8.13 2.34am 0 1 0 5 0 2 3 2 7 8 0 0 0 0 0 0 0 0 0 0 0 0 0 0
53 0 2.11.12 11.37am 1 2 4 9 0 1 4 3 5 6 0 0 0 0 0 0 0 0 0 0 0 0 0 0
54 0 2.11.12 11.10pm 0 1 0 5 9 2 3 2 5 6 0 0 0 0 0 0 1 0 0 0 0 0 0 0  
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55 Manju 19 20004 1 0 0 0 1.11.12 7.22am 23.2.12 30.11.12 36 36 36 Act 0 158 66 2 5 44 3 11
56 Parimala 23 18933 1 0 0 0 4.11.12 6.30am 2.3.13 9.12.13 35 35 35 Exp 1 162 54 2 5 3 1 0
57 Mariammal 19 19358 2 1 1 0 23.10.13 8.05pm 5.3.13 12.12.13 33 33 33 Exp 0 152 56 3 5 18 2 0
58 Dhavamani 30 19287 3 2 2 0 22.10.13 11.40pm 11.40pm 27.11.13 34 34 34 Exp 2 156 52 3 5 10 2 1
59 Vani 28 18565 3 1 1 1 13.10.13 4.45am 4.45am 6.2.13 32 32 32 Act 0 156 61 2 4 7 2 0
60 Israth begam 19 19679 1 0 0 0 28.10.13 10.17am 10.17am 22.11.13 36 36 36 Act 0 154 52 2 5 18 3 1
61 Kamakshi 26 19542 2 1 1 0 26.10.13 6.45am 6.45am 22.11.13 36 36 36 Act 0 167 73 1 5 23 3 1
62 Rahima 21 19527 1 0 0 0 29.9.13 11.10pm 27.1.13 3.11.13 35 35 35 Act 0 152 56 1 5 18 3 1
63 Amaravathy 27 19391 2 1 1 0 24.10.13 11.05am 7.2.13 14.12.12 33 33 33 Exp 0 156 75 3 5 4 1 0
64 Chitra 24 13452 1 0 0 0 5.9.13 11.45pm 28.12.12 5.10.13 36 36 36 Act 0 156 67 1 5 18 3 1
65 Tamilselvi 23 7342 2 1 1 0 2.5.13 6.24am 4.9.12 11.6.13 34 34 34 Act 0 150 74 1 5 33 4 1
66 Selvi 18 7457 1 0 0 0 2.5.13 3.42am 20.8.12 27.5.13 36 36 36 Exp 0 165 75 1 5 7 2 0
67 Usharani 30 7641 2 1 1 0 6.5.13 5.10am 1.9.12 7.6.13 35 35 35 Act 0 151 74 2 4 13 3 1
68 kanimozhi 28 7787 1 0 0 0 10.5.13 2.55am 10.9.12 17.6.13 34 34 34 Exp 0 156 68 1 4 12 2 0
69 Mangai 25 7812 1 0 0 0 10.5.13 4.25am 28.8.12 5.6.13 36 36 34 Act 0 159 53 2 4 2 1 1
70 Ponni 21 8121 1 0 0 0 16.5.13 7.25am 4.9.12 11.6.13 36 36 36 Act 0 166 64 2 5 21 3 1
71 Sumathy 27 8146 2 1 0 0 16.5.13 11.35pm 12.9.12 19.6.13 35 35 35 Exp 1 151 64 1 5 7 2 0
72 Rajeswari 28 8264 1 0 0 0 21.5.13 8.12am 24.9.12 1.7.13 34 34 34 Exp 0 153 64 2 4 3 1 0
73 Badurnisha 23 8275 1 0 0 0 21.5.13 4.20pm 3.10.13 10.7.13 33 33 33 Exp 2 163 63 2 5 2 1 1
74 Radha 31 8494 3 1 1 1 26.5.13 10.20pm 14.9.12 21.6.13 36 36 36 Act 0 157 53 1 5 23 3 0
75 Menaka 26 8609 1 0 0 0 30.5.13 3.50am 25.9.12 2.7.13 35 35 35 Act 0 152 70 1 4 19 3 0
76 Jayalakshmi 24 8551 3 1 0 1 30.5.13 4.30am 10.10.12 17.7.13 33 33 33 Act 1 157 52 1 5 45 4 1
77 Munira 25 8594 1 0 0 0 2.6.13 2.35am 5.10.12 12.7.13 34 34 34 Exp 0 160 75 1 5 6 1 0
78 Kalpana 24 204 1 0 0 0 5.1.13 6.13am 24.5.12 1.3.13 32 32 32 Act 0 153 71 2 5 40 4 1
79 Selvi 25 343 1 0 0 0 6.1.13 12.15pm 5.5.12 12.2.13 35 35 35 Act 0 156 73 1 4 40 4 1
80 Pavithra devi 26 412 2 1 1 0 9.1.13 4.15am 30.4.12 7.2.13 36 36 36 Exp 0 162 61 2 5 8 2 0
81 sheela 28 645 1 0 0 0 12.1.13 7.25pm 5.5.12 12.2.13 36 36 36 Act 0 155 56 1 3 47 4 1
82 Geetha 18 699 1 0 0 0 15.1.13 8.15pm 20.5.12 27.7.13 34 34 34 Act 0 168 67 1 4 17 3 1  
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55 0 1.11.12 10.35am 1 1 0 3 0 1 5 4 4 5 0 0 0 0 0 0 0 0 0 0 0 0 0 0
56 0 5.11.13 2.15pm 0 2 2 10 0 2 3 3 7 8 1 0 0 0 0 0 0 0 0 0 0 0 0 0
57 0 25.10.13 10.35am 0 1 0 4 10 1 2 2 4 5 1 0 0 0 1 0 0 0 0 0 0 0 0 0
58 0 24.10.13 5.15pm 1 1 0 5 24 1 3 2 1 4 0 1 0 0 0 0 0 0 0 0 0 0 0 0
59 0 18.10.13 12.05pm 0 2 2 9 12 1 1 2 4 5 0 1 0 1 0 0 0 0 0 0 0 0 0 0
60 0 28.10.13 1.40pm 1 1 0 3 0 2 5 4 5 6 0 0 0 0 0 0 0 0 0 0 0 0 0 0
61 0 26.10.13 9am 1 1 0 3 7 1 5 3 4 5 1 0 0 0 0 0 0 0 0 0 0 0 0 0
62 0 30.9.13 7.10am 2 2 1 8 0 1 4 3 4 5 0 0 0 0 0 0 0 0 0 0 0 0 0 0
63 0 27.10.13 8.25am 0 1 0 5 7 1 2 2 8 9 0 0 0 0 1 0 0 0 0 0 0 0 1 0
64 0 6.9..13 9.04am 2 1 0 3 4 1 5 3 6 7 0 0 0 0 0 1 0 0 0 0 0 0 0 0
65 0 2.5.13 1.18pm 1 1 0 3 7 2 3 3 8 9 0 1 0 1 0 0 0 0 0 0 0 0 0 0
66 0 4.5.13 5.45am 0 2 2 8 8 1 5 3 7 8 0 1 0 0 0 0 0 0 0 0 0 0 0 0
67 0 6.5.13 10.20am 1 2 4 10 7 2 4 3 6 7 0 1 0 0 0 0 0 0 0 0 0 0 0 0
68 0 11.5.13 10.35am 0 2 3 10 10 2 3 2 4 6 0 0 0 0 1 0 0 0 0 0 0 0 0 0
69 0 10.5.13 9.27am 1 3 0 5 0 2 5 4 7 8 0 0 0 0 0 0 0 0 0 0 0 0 0 0
70 0 16.5.13 3.25pm 1 2 4 8 0 1 5 4 7 8 0 0 0 0 0 0 0 0 0 0 0 0 0 0
71 0 18.5.13 6.55pm 0 1 0 5 0 2 4 3 7 8 1 0 0 0 0 0 0 0 0 0 0 0 0 1
72 0 22.5.13 12.08pm 0 1 0 5 6 2 3 3 4 7 0 0 0 0 0 0 0 0 0 0 0 0 0 0
73 0 24.5.13 12.20pm 0 1 0 6 9 2 2 2 8 9 1 0 1 0 0 0 0 0 0 0 0 0 0 0
74 0 27.5.13 6.29am 1 1 0 3 0 1 5 4 7 8 0 0 0 0 0 0 0 0 0 0 0 0 0 0
75 0 30.5.13 5.13am 1 2 4 8 5 2 4 3 7 8 0 0 0 0 0 0 0 1 0 0 0 0 0 0
76 0 31.5.13 5.35pm 0 1 0 4 3 1 2 3 8 9 0 1 1 0 0 0 0 0 0 0 0 0 0 0
77 0 3.6.13 8.55pm 0 1 0 5 8 1 3 2 7 8 0 0 1 0 0 0 0 0 0 0 0 0 0 0
78 0 4.1.13 11.48pm 1 1 0 3 12 2 1 2 5 6 0 1 0 0 0 0 0 0 0 0 0 0 0 0
79 0 6.1.13 11.08pm 1 1 0 3 0 1 4 3 7 8 0 0 0 0 0 0 0 0 0 0 0 0 0 0
80 0 9.1.13 11.40pm 0 1 0 5 8 1 5 3 6 8 0 0 0 0 0 0 1 0 0 0 0 0 0 0
81 0 13.1.13 5.30am 1 2 1 8 0 2 5 3 7 8 0 0 0 0 0 0 0 0 0 0 0 0 0 0
82 0 15.1.13 11.58pm 1 1 0 3 8 2 3 3 4 6 0 1 0 0 0 0 0 0 0 0 0 0 0 0  
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83 Chandrakala 25 721 1 0 0 0 14.1.13 7.50pm 5.6.12 12.3.13 32 32 32 Exp 0 168 56 1 4 1 1 0
84 suganya 23 806 1 0 0 0 17.1.13 1.05am 21.5.12 28.2.13 34 34 34 Exp 3 154 55 2 5 6 1 1
85 Vimala 29 821 3 1 1 1 23.1.13 4.50am 15.5.12 22.2.13 36 36 36 Act 0 159 69 2 4 24 3 1
86 Umadevi 21 908 1 0 0 0 24.1.13 8.45pm 24.5.12 1.3.13 35 35 35 Act 0 158 58 2 5 23 3 0
87 Mogambika 23 1195 1 0 0 0 2.2.13 8.20pm 26.5.12 3.3.13 36 36 36 Exp 0 165 73 1 5 10 2 0
88 Sandiya 24 1211 1 0 0 0 4.2.13 10.50pm 27.5.12 4.3.13 36 36 36 Exp 0 153 74 1 5 1 1 0
89 Kuppammal 20 1345 1 0 0 0 7.2.13 9.15am 13.6.12 20.3.13 34 34 34 Exp 0 154 70 1 5 1 1 0
90 Parvathy 26 1724 1 0 0 0 16.2.13 1.45am 28.6.12 5.4.13 34 34 34 Act 0 157 57 1 4 24 3 1
91 Swapna 21 1821 4 2 2 1 18.2.13 12.45am 10.6.12 17.3.13 36 36 36 Exp 0 159 56 3 5 1 1 0
92 Sathya 23 2421 3 2 2 0 1.3.13 9.37am 20.6.12 27.3.13 36 36 36 Act 0 161 74 3 4 28 4 1
93 Vasanthi 23 12415 2 1 1 0 19.7.13 7.45am 28.11.12 5.9.13 33 33 33 Act 0 155 58 2 5 77 4 1
94 Kanthamani 25 2525 1 0 0 0 8.3.13 8.35am 11.7.12 18.4.13 34 34 34 Exp 1 158 59 4 5 6 1 0
95 Rosy 22 18942 1 0 0 0 13.10.13 1.30pm 1.2.13 8.11.13 36 36 36 Act 0 153 63 1 4 14 3 1
96 Selvi 29 19053 2 1 1 0 17.10.13 9.35pm 6.2.13 13.11.13 36 36 36 Act 0 152 73 2 4 17 3 1
97 Sumathy 25 19547 1 0 0 0 18.10.13 6pm 8.2.13 15.11.13 36 36 36 Act 0 163 69 1 4 23 3 1
98 Sugitha 28 13214 2 1 1 0 3.8.13 10.30am 6.12.12 13.9.13 34 34 34 Exp 0 154 50 1 5 3 1 0
99 Krithika 25 13116 1 0 0 0 4.8.13 2.10pm 24.11.12 1.8,13 36 36 36 Act 0 167 50 1 4 13 3 1
100 Renuka 24 13097 1 0 0 0 29.7.13 9.10pm 16.11.12 23.8.13 36 36 36 Act 0 156 69 2 4 21 3 1
101 Gayathri 21 12954 1 0 0 0 25.7.13 3.56pm 20.11.12 27.8.13 35 35 35 Exp 0 153 60 2 5 1 1 0
102 Roopa devi 25 19548 2 1 0 0 28.10.13 3.40pm 20.2.13 27.11.13 36 36 36 Exp 0 162 64 1 5 12 2 0
103 Madhubala 21 19360 1 0 0 0 23.10.13 8pm 5.3.13 12.12.13 33 33 33 Exp 1 156 49 2 5 3 1 0
104 Thenmozhi 29 18841 2 1 1 0 11.10.13 2.30pm 12.2.13 19.11.13 34 34 34 Act 0 161 61 1 5 25 4 1
105 Saranya 23 18894 2 1 1 0 12.10.13 5.13am 6.2.13 13.11.13 35 35 35 Act 0 159 65 2 4 19 3 1
106 Narfez 24 13032 1 0 0 0 28.7.13 4.05pm 1.12.12 8.9.13 34 34 34 Act 0 160 60 3 3 48 4 1
107 Bhavani devi 18 13945 1 0 0 0 18.8.13 2.50am 7.2.12 14.9.13 36 36 36 Act 0 150 72 3 5 26 4 1
108 Pandiselvi 25 16150 2 0 0 1 14.9.13 7.40am 10.1.13 17.10.13 36 36 36 Exp 0 150 54 1 4 2 1 0  
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83 0 18.1.13 12.50am 0 1 0 5 7 2 1 2 4 5 1 0 0 0 0 0 0 1 0 0 0 0 0 0
84 0 18.1.13 11.55pm 0 1 0 5 4 1 3 3 8 9 0 0 0 1 0 0 0 0 0 0 0 0 0 0
85 0 23.1.13 10.40am 1 1 0 3 8 1 5 3 7 8 0 0 0 0 0 0 1 0 0 0 0 0 0 0
86 0 25.1.13 6.30am 1 1 0 3 9 1 4 3 7 8 0 1 0 0 0 0 1 0 0 0 0 0 0 0
87 0 3.2.13 10.45am 0 1 0 5 7 1 4 3 7 8 0 0 1 0 0 0 0 0 0 0 0 0 0 0
88 0 5.2.13 12.45pm 0 1 0 9 7 2 5 3 7 9 0 0 0 0 0 0 1 0 0 1 0 0 0 0
89 0 8.2.13 11.30pm 0 1 0 6 6 1 3 3 8 9 0 0 1 0 0 0 0 0 0 0 0 0 0 0
90 0 16.2.13 9.40am 1 1 0 3 0 2 3 3 6 7 0 0 0 0 0 0 0 0 0 0 0 0 0 0
91 0 18.2.13 11.30pm 0 1 0 5 0 1 5 5 7 8 0 0 0 0 0 0 0 0 0 0 0 0 0 0
92 0 1.3.13 1.10pm 1 2 1 8 6 1 5 4 7 8 0 0 0 0 0 0 0 0 0 0 0 0 0 0
93 0 19.7.13 12.05pm 1 1 0 7 12 2 2 2 4 7 0 1 1 0 0 0 0 0 0 0 0 0 0 0
94 0 9.3.13 6.28am 0 1 0 5 11 2 3 2 7 8 0 0 1 0 0 0 0 0 0 0 0 0 0 0
95 0 13.10.13 4.03pm 1 2 4 8 6 1 5 4 2 5 0 0 0 0 1 0 0 0 0 0 0 0 0 0
96 0 18.10.13 3.15am 1 1 0 5 0 2 5 5 7 8 0 0 0 0 0 0 0 0 0 0 0 0 0 0
97 0 19.10.13 4.17am 2 1 0 5 0 1 5 4 7 9 0 0 0 0 0 0 0 0 0 0 0 0 0 0
98 0 6.8.13 11.40am 0 2 2 14 10 1 3 2 5 7 0 0 1 0 0 0 0 0 0 0 0 0 0 0
99 0 4.8.13 8.55pm 1 1 0 5 5 1 5 3 7 8 0 0 0 0 0 0 0 0 0 0 0 0 0 0
100 0 30.7.13 12.20am 1 1 0 4 8 1 5 3 4 6 0 0 0 1 0 0 0 0 0 0 0 0 0 0
101 0 29.7.13 9.15pm 0 2 2 14 4 2 4 3 6 8 0 0 0 1 0 0 0 0 0 0 0 0 0 0
102 0 30.10.13 1.25am 0 1 0 6 9 2 5 3 4 6 0 0 0 0 1 0 0 0 0 0 0 0 0 0
103 0 24.10.13 9.05pm 0 1 0 5 8 2 2 2 6 7 1 0 1 0 0 0 0 0 0 0 0 0 0 0
104 0 11.10.13 5.20PM 1 1 0 3 8 1 3 2 6 7 0 1 0 0 0 0 0 0 0 0 0 0 0 0
105 0 12.10.13 12.07pm 1 1 0 4 3 2 4 4 7 8 1 1 0 0 0 1 0 0 0 0 0 0 0 0
106 0 28.7.13 10pm 1 1 0 7 8 1 3 2 5 7 0 0 0 0 0 0 0 0 0 0 0 0 0 0
107 0 18.8.13 1.52pm 1 1 0 4 8 1 5 3 3 5 0 0 0 0 1 0 0 0 0 0 0 0 0 0
108 0 16.9.13 6.20am 0 1 0 5 0 2 5 3 7 8 0 0 0 0 0 0 0 0 0 0 0 0 0 0  
 xii 
 
Code 
HVS   :  0-No growth, 1-E-Coli, 2.S.Aureus. 3. Klebsiella  
Education  :  1- <6
th
 STD, 2- 6-10 STD, 3- 10-12 STD, 4- Degree 
SE status  :  1-Administrative, 2-Professional, 3. Skilled 4-Semi skilled-Fixed, 5-4-Semi skilled-Daily wages 
Duration of MRO : 1- <6hrs, 2- 6-12 hrs, 3- 12-24 hrs, 4- >24hrs 
Oxytocin/PGE induction: 0- Not given, 1- Given 
Mode of Delivery :  1-Labour Naturals, 2-LSCS, 3-Forceps delivery 
Indication for LSCS :   1. Failure to progress, 2.Breech with oligohydraminos, 3- Fetal distress, 4- Severe Oligohydramnios. 
Sex of the baby : 1-Boy, 2-Girl  
Baby Gestational Age :  1-32, 2-33, 3-34, 4-35, 5-36. 
Baby weight  :  1-<1.5 kgs,2- 1.5 to 2kgs, 3- 2-2.5 kgs, 4- >2.5 kgs 
Septicemia, RDS, LBW, preterm, Asphyxia, Hypoglycemia, NEC,Others, Maternal puerperium, Fever, Tachycardia, Foul VD, Abruption, 
Chorioamnionitis         :            0-Not present, 1-present. 
 
 
